KR20220170290A - 한국형 살무사과 사독의 항사독 조성물 - Google Patents
한국형 살무사과 사독의 항사독 조성물 Download PDFInfo
- Publication number
- KR20220170290A KR20220170290A KR1020210081139A KR20210081139A KR20220170290A KR 20220170290 A KR20220170290 A KR 20220170290A KR 1020210081139 A KR1020210081139 A KR 1020210081139A KR 20210081139 A KR20210081139 A KR 20210081139A KR 20220170290 A KR20220170290 A KR 20220170290A
- Authority
- KR
- South Korea
- Prior art keywords
- viper
- ser
- glu
- leu
- gly
- Prior art date
Links
- 230000002303 anti-venom Effects 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 231100000611 venom Toxicity 0.000 title abstract description 21
- 239000002435 venom Substances 0.000 title abstract description 16
- 210000001048 venom Anatomy 0.000 title abstract description 16
- 241000271897 Viperidae Species 0.000 claims abstract description 136
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 52
- 210000002966 serum Anatomy 0.000 claims abstract description 49
- 241001465754 Metazoa Species 0.000 claims abstract description 32
- 231100000614 poison Toxicity 0.000 claims description 59
- 239000002574 poison Substances 0.000 claims description 54
- 239000003053 toxin Substances 0.000 claims description 16
- 231100000765 toxin Toxicity 0.000 claims description 16
- 241001137251 Corvidae Species 0.000 claims description 15
- 239000002671 adjuvant Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 9
- 101000998548 Yersinia ruckeri Alkaline proteinase inhibitor Proteins 0.000 claims description 7
- 239000003475 metalloproteinase inhibitor Substances 0.000 claims description 7
- 239000003998 snake venom Substances 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 34
- 102000004169 proteins and genes Human genes 0.000 description 29
- 235000018102 proteins Nutrition 0.000 description 28
- 241001487808 Protobothrops mucrosquamatus Species 0.000 description 26
- 230000001147 anti-toxic effect Effects 0.000 description 22
- 241000168490 Gloydius intermedius Species 0.000 description 20
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 18
- 241001421573 Gloydius brevicaudus Species 0.000 description 18
- 108010006035 Metalloproteases Proteins 0.000 description 18
- 102000005741 Metalloproteases Human genes 0.000 description 18
- 241000270295 Serpentes Species 0.000 description 18
- 241000271042 Gloydius halys Species 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 108700012359 toxins Proteins 0.000 description 14
- 239000002243 precursor Substances 0.000 description 13
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 10
- 102100032491 Serine protease 1 Human genes 0.000 description 10
- 101710151387 Serine protease 1 Proteins 0.000 description 10
- 230000036961 partial effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000002821 viper venom Substances 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 102100037611 Lysophospholipase Human genes 0.000 description 9
- 108010058864 Phospholipases A2 Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 241000271527 Crotalus adamanteus Species 0.000 description 8
- 241001494884 Gloydius ussuriensis Species 0.000 description 8
- 101710101817 Keratin, type II cytoskeletal Proteins 0.000 description 8
- 108010044292 tryptophyltyrosine Proteins 0.000 description 8
- 241000987738 Gloydius blomhoffii Species 0.000 description 7
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 7
- 108010029485 Protein Isoforms Proteins 0.000 description 7
- 102000001708 Protein Isoforms Human genes 0.000 description 7
- 102000012479 Serine Proteases Human genes 0.000 description 7
- 108010022999 Serine Proteases Proteins 0.000 description 7
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 7
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 7
- 101710116680 Acidic phospholipase A2 Proteins 0.000 description 6
- 240000001890 Ribes hudsonianum Species 0.000 description 6
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 6
- 235000001466 Ribes nigrum Nutrition 0.000 description 6
- 108010016616 cysteinylglycine Proteins 0.000 description 6
- 229960003722 doxycycline Drugs 0.000 description 6
- 230000002779 inactivation Effects 0.000 description 6
- 241001502277 Agkistrodon contortrix laticinctus Species 0.000 description 5
- HCAUEJAQCXVQQM-ACZMJKKPSA-N Asn-Glu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HCAUEJAQCXVQQM-ACZMJKKPSA-N 0.000 description 5
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 5
- BZULIEARJFRINC-IHRRRGAJSA-N Gln-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N BZULIEARJFRINC-IHRRRGAJSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 102100029144 Histone-lysine N-methyltransferase PRDM9 Human genes 0.000 description 5
- 101001124887 Homo sapiens Histone-lysine N-methyltransferase PRDM9 Proteins 0.000 description 5
- 102000001938 Plasminogen Activators Human genes 0.000 description 5
- 108010001014 Plasminogen Activators Proteins 0.000 description 5
- 101710111620 Protein C activator Proteins 0.000 description 5
- 101710173623 Snake venom serine protease Proteins 0.000 description 5
- FLPZMPOZGYPBEN-PPCPHDFISA-N Thr-Leu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLPZMPOZGYPBEN-PPCPHDFISA-N 0.000 description 5
- 102000018472 Type I Keratins Human genes 0.000 description 5
- 108010091525 Type I Keratins Proteins 0.000 description 5
- 108010005233 alanylglutamic acid Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003436 cytoskeletal effect Effects 0.000 description 5
- 229940069417 doxy Drugs 0.000 description 5
- HALQELOKLVRWRI-VDBOFHIQSA-N doxycycline hyclate Chemical group O.[Cl-].[Cl-].CCO.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O HALQELOKLVRWRI-VDBOFHIQSA-N 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 108010018006 histidylserine Proteins 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 229940127126 plasminogen activator Drugs 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000271043 Agkistrodon piscivorus Species 0.000 description 4
- AHPWQERCDZTTNB-FXQIFTODSA-N Arg-Cys-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N AHPWQERCDZTTNB-FXQIFTODSA-N 0.000 description 4
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 4
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 4
- 101710144874 Basic phospholipase A2 Proteins 0.000 description 4
- 241000271537 Crotalus atrox Species 0.000 description 4
- GHUVBPIYQYXXEF-SRVKXCTJSA-N Cys-Cys-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 GHUVBPIYQYXXEF-SRVKXCTJSA-N 0.000 description 4
- JIZRUFJGHPIYPS-SRVKXCTJSA-N Cys-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N)O JIZRUFJGHPIYPS-SRVKXCTJSA-N 0.000 description 4
- OBIHEDRRSMRKLU-ACZMJKKPSA-N Glu-Cys-Asp Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OBIHEDRRSMRKLU-ACZMJKKPSA-N 0.000 description 4
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 4
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 4
- YLMIDMSLKLRNHX-HSCHXYMDSA-N Leu-Trp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YLMIDMSLKLRNHX-HSCHXYMDSA-N 0.000 description 4
- DTICLBJHRYSJLH-GUBZILKMSA-N Met-Ala-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O DTICLBJHRYSJLH-GUBZILKMSA-N 0.000 description 4
- NKDSBBBPGIVWEI-RCWTZXSCSA-N Met-Arg-Thr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NKDSBBBPGIVWEI-RCWTZXSCSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 4
- 101710090535 Neutral phospholipase A2 agkistrodotoxin Proteins 0.000 description 4
- FXEKNHAJIMHRFJ-ULQDDVLXSA-N Phe-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N FXEKNHAJIMHRFJ-ULQDDVLXSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 4
- 208000004078 Snake Bites Diseases 0.000 description 4
- 102000007962 Type II Keratins Human genes 0.000 description 4
- 108010089374 Type II Keratins Proteins 0.000 description 4
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 4
- 108010092854 aspartyllysine Proteins 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 108010073969 valyllysine Proteins 0.000 description 4
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 3
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 3
- FOHXUHGZZKETFI-JBDRJPRFSA-N Ala-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N FOHXUHGZZKETFI-JBDRJPRFSA-N 0.000 description 3
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 3
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 3
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 3
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 3
- GHNDBBVSWOWYII-LPEHRKFASA-N Arg-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GHNDBBVSWOWYII-LPEHRKFASA-N 0.000 description 3
- PQWTZSNVWSOFFK-FXQIFTODSA-N Arg-Asp-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)CN=C(N)N PQWTZSNVWSOFFK-FXQIFTODSA-N 0.000 description 3
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 3
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 3
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 3
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 3
- OEDJQRXNDRUGEU-SRVKXCTJSA-N Asp-Leu-His Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O OEDJQRXNDRUGEU-SRVKXCTJSA-N 0.000 description 3
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 3
- 238000011740 C57BL/6 mouse Methods 0.000 description 3
- 241001490936 Crotalus horridus Species 0.000 description 3
- KGIHMGPYGXBYJJ-SRVKXCTJSA-N Cys-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS KGIHMGPYGXBYJJ-SRVKXCTJSA-N 0.000 description 3
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 3
- AQPZYBSRDRZBAG-AVGNSLFASA-N Gln-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N AQPZYBSRDRZBAG-AVGNSLFASA-N 0.000 description 3
- 101001121406 Gloydius blomhoffii L-amino-acid oxidase Proteins 0.000 description 3
- VFZIDQZAEBORGY-GLLZPBPUSA-N Glu-Gln-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VFZIDQZAEBORGY-GLLZPBPUSA-N 0.000 description 3
- QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 description 3
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 3
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 3
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 3
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 3
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 3
- QGDOOCIPHSSADO-STQMWFEESA-N Gly-Met-Phe Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGDOOCIPHSSADO-STQMWFEESA-N 0.000 description 3
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 3
- KMBPQYKVZBMRMH-PEFMBERDSA-N Ile-Gln-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O KMBPQYKVZBMRMH-PEFMBERDSA-N 0.000 description 3
- 101710183399 Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 3
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 3
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 3
- 241000270322 Lepidosauria Species 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 3
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 3
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 3
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 3
- YAWKHFKCNSXYDS-XIRDDKMYSA-N Met-Glu-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N YAWKHFKCNSXYDS-XIRDDKMYSA-N 0.000 description 3
- KMSMNUFBNCHMII-IHRRRGAJSA-N Met-Leu-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN KMSMNUFBNCHMII-IHRRRGAJSA-N 0.000 description 3
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 3
- PZSCUPVOJGKHEP-CIUDSAMLSA-N Pro-Gln-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O PZSCUPVOJGKHEP-CIUDSAMLSA-N 0.000 description 3
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 3
- CHYAYDLYYIJCKY-OSUNSFLBSA-N Pro-Thr-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CHYAYDLYYIJCKY-OSUNSFLBSA-N 0.000 description 3
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 3
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 3
- WYKJENSCCRJLRC-ZDLURKLDSA-N Thr-Gly-Cys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)O WYKJENSCCRJLRC-ZDLURKLDSA-N 0.000 description 3
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 3
- FPCIBLUVDNXPJO-XPUUQOCRSA-N Val-Cys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FPCIBLUVDNXPJO-XPUUQOCRSA-N 0.000 description 3
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 3
- 101710099833 Venom protein Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 108010062796 arginyllysine Proteins 0.000 description 3
- 239000000179 crotalid venom Substances 0.000 description 3
- 108010060199 cysteinylproline Proteins 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 3
- 108010015792 glycyllysine Proteins 0.000 description 3
- 108010037850 glycylvaline Proteins 0.000 description 3
- 108010036413 histidylglycine Proteins 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 3
- 108010053037 kyotorphin Proteins 0.000 description 3
- 108010057821 leucylproline Proteins 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000000053 physical method Methods 0.000 description 3
- 108010071207 serylmethionine Proteins 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 2
- YSMPVONNIWLJML-FXQIFTODSA-N Ala-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O YSMPVONNIWLJML-FXQIFTODSA-N 0.000 description 2
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 2
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 2
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 2
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 2
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 2
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 2
- KLKARCOHVHLAJP-UWJYBYFXSA-N Ala-Tyr-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(O)=O KLKARCOHVHLAJP-UWJYBYFXSA-N 0.000 description 2
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 2
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 2
- XTGGTAWGUFXJSV-NAKRPEOUSA-N Arg-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N XTGGTAWGUFXJSV-NAKRPEOUSA-N 0.000 description 2
- JAYIQMNQDMOBFY-KKUMJFAQSA-N Arg-Glu-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JAYIQMNQDMOBFY-KKUMJFAQSA-N 0.000 description 2
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 2
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 2
- QEYJFBMTSMLPKZ-ZKWXMUAHSA-N Asn-Ala-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QEYJFBMTSMLPKZ-ZKWXMUAHSA-N 0.000 description 2
- NKTLGLBAGUJEGA-BIIVOSGPSA-N Asn-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N)C(=O)O NKTLGLBAGUJEGA-BIIVOSGPSA-N 0.000 description 2
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 2
- BXUHCIXDSWRSBS-CIUDSAMLSA-N Asn-Leu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BXUHCIXDSWRSBS-CIUDSAMLSA-N 0.000 description 2
- PLOKOIJSGCISHE-BYULHYEWSA-N Asp-Val-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLOKOIJSGCISHE-BYULHYEWSA-N 0.000 description 2
- 102100021277 Beta-secretase 2 Human genes 0.000 description 2
- 101710150190 Beta-secretase 2 Proteins 0.000 description 2
- 101000772006 Bombus ignitus Venom serine protease Bi-VSP Proteins 0.000 description 2
- 241000168549 Bothriechis schlegelii Species 0.000 description 2
- 241000271515 Bothrops insularis Species 0.000 description 2
- 101710201511 Coagulation factor X-activating enzyme heavy chain Proteins 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 101000774559 Crotalus atrox Zinc metalloproteinase-disintegrin-like VAP2A Proteins 0.000 description 2
- TVYMKYUSZSVOAG-ZLUOBGJFSA-N Cys-Ala-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O TVYMKYUSZSVOAG-ZLUOBGJFSA-N 0.000 description 2
- UWXFFVQPAMBETM-ZLUOBGJFSA-N Cys-Asp-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UWXFFVQPAMBETM-ZLUOBGJFSA-N 0.000 description 2
- PFAQXUDMZVMADG-AVGNSLFASA-N Cys-Gln-Tyr Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PFAQXUDMZVMADG-AVGNSLFASA-N 0.000 description 2
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 2
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 2
- SWJYSDXMTPMBHO-FXQIFTODSA-N Cys-Pro-Ser Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SWJYSDXMTPMBHO-FXQIFTODSA-N 0.000 description 2
- MWVDDZUTWXFYHL-XKBZYTNZSA-N Cys-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)N)O MWVDDZUTWXFYHL-XKBZYTNZSA-N 0.000 description 2
- 241001505404 Deinagkistrodon acutus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- QYTKAVBFRUGYAU-ACZMJKKPSA-N Gln-Asp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QYTKAVBFRUGYAU-ACZMJKKPSA-N 0.000 description 2
- DAAUVRPSZRDMBV-KBIXCLLPSA-N Gln-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N DAAUVRPSZRDMBV-KBIXCLLPSA-N 0.000 description 2
- 241000330954 Gloydius saxatilis Species 0.000 description 2
- 241001487870 Gloydius strauchi Species 0.000 description 2
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 2
- RTOOAKXIJADOLL-GUBZILKMSA-N Glu-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N RTOOAKXIJADOLL-GUBZILKMSA-N 0.000 description 2
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 2
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 2
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 2
- LGYCLOCORAEQSZ-PEFMBERDSA-N Glu-Ile-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O LGYCLOCORAEQSZ-PEFMBERDSA-N 0.000 description 2
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 2
- VXEFAWJTFAUDJK-AVGNSLFASA-N Glu-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O VXEFAWJTFAUDJK-AVGNSLFASA-N 0.000 description 2
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 2
- HDNXXTBKOJKWNN-WDSKDSINSA-N Gly-Glu-Asn Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O HDNXXTBKOJKWNN-WDSKDSINSA-N 0.000 description 2
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 2
- UYPPAMNTTMJHJW-KCTSRDHCSA-N Gly-Ile-Trp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O UYPPAMNTTMJHJW-KCTSRDHCSA-N 0.000 description 2
- YIFUFYZELCMPJP-YUMQZZPRSA-N Gly-Leu-Cys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O YIFUFYZELCMPJP-YUMQZZPRSA-N 0.000 description 2
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 2
- PYFIQROSWQERAS-LBPRGKRZSA-N Gly-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(=O)NCC(O)=O)=CNC2=C1 PYFIQROSWQERAS-LBPRGKRZSA-N 0.000 description 2
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 2
- RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 2
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 2
- UOYGZBIPZYKGSH-SRVKXCTJSA-N His-Ser-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N UOYGZBIPZYKGSH-SRVKXCTJSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 2
- KIAOPHMUNPPGEN-PEXQALLHSA-N Ile-Gly-His Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KIAOPHMUNPPGEN-PEXQALLHSA-N 0.000 description 2
- TWYOYAKMLHWMOJ-ZPFDUUQYSA-N Ile-Leu-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O TWYOYAKMLHWMOJ-ZPFDUUQYSA-N 0.000 description 2
- RFMDODRWJZHZCR-BJDJZHNGSA-N Ile-Lys-Cys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O RFMDODRWJZHZCR-BJDJZHNGSA-N 0.000 description 2
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 2
- SWNRZNLXMXRCJC-VKOGCVSHSA-N Ile-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 SWNRZNLXMXRCJC-VKOGCVSHSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 2
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 2
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- WLCYCADOWRMSAJ-CIUDSAMLSA-N Lys-Asn-Cys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(O)=O WLCYCADOWRMSAJ-CIUDSAMLSA-N 0.000 description 2
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- WWEWGPOLIJXGNX-XUXIUFHCSA-N Lys-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)N WWEWGPOLIJXGNX-XUXIUFHCSA-N 0.000 description 2
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 2
- USPJSTBDIGJPFK-PMVMPFDFSA-N Lys-Tyr-Trp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O USPJSTBDIGJPFK-PMVMPFDFSA-N 0.000 description 2
- ODFBIJXEWPWSAN-CYDGBPFRSA-N Met-Ile-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O ODFBIJXEWPWSAN-CYDGBPFRSA-N 0.000 description 2
- DJJBHQHOZLUBCN-WDSOQIARSA-N Met-Lys-Trp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DJJBHQHOZLUBCN-WDSOQIARSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- QEPZQAPZKIPVDV-KKUMJFAQSA-N Phe-Cys-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N QEPZQAPZKIPVDV-KKUMJFAQSA-N 0.000 description 2
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 2
- BSHMIVKDJQGLNT-ACRUOGEOSA-N Phe-Lys-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 BSHMIVKDJQGLNT-ACRUOGEOSA-N 0.000 description 2
- WKLMCMXFMQEKCX-SLFFLAALSA-N Phe-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O WKLMCMXFMQEKCX-SLFFLAALSA-N 0.000 description 2
- VFDRDMOMHBJGKD-UFYCRDLUSA-N Phe-Tyr-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N VFDRDMOMHBJGKD-UFYCRDLUSA-N 0.000 description 2
- ZOGICTVLQDWPER-UFYCRDLUSA-N Phe-Tyr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O ZOGICTVLQDWPER-UFYCRDLUSA-N 0.000 description 2
- 108010079005 RDV peptide Proteins 0.000 description 2
- HBOABDXGTMMDSE-GUBZILKMSA-N Ser-Arg-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O HBOABDXGTMMDSE-GUBZILKMSA-N 0.000 description 2
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 2
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 2
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 2
- 101710176087 Snaclec rhodocetin subunit alpha Proteins 0.000 description 2
- 101710154810 Snake venom metalloproteinase Proteins 0.000 description 2
- 101710144366 Snake venom metalloproteinase acutolysin-C Proteins 0.000 description 2
- 101710148647 Snake venom metalloproteinase basparin-A Proteins 0.000 description 2
- 101710177459 Snake venom metalloproteinase fibrolase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PXQUBKWZENPDGE-CIQUZCHMSA-N Thr-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)N PXQUBKWZENPDGE-CIQUZCHMSA-N 0.000 description 2
- VASYSJHSMSBTDU-LKXGYXEUSA-N Thr-Asn-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)O VASYSJHSMSBTDU-LKXGYXEUSA-N 0.000 description 2
- LXWZOMSOUAMOIA-JIOCBJNQSA-N Thr-Asn-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O LXWZOMSOUAMOIA-JIOCBJNQSA-N 0.000 description 2
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 2
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 2
- NIWAGRRZHCMPOY-GMVOTWDCSA-N Trp-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N NIWAGRRZHCMPOY-GMVOTWDCSA-N 0.000 description 2
- DANHCMVVXDXOHN-SRVKXCTJSA-N Tyr-Asp-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DANHCMVVXDXOHN-SRVKXCTJSA-N 0.000 description 2
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 2
- ILTXFANLDMJWPR-SIUGBPQLSA-N Tyr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N ILTXFANLDMJWPR-SIUGBPQLSA-N 0.000 description 2
- GITNQBVCEQBDQC-KKUMJFAQSA-N Tyr-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O GITNQBVCEQBDQC-KKUMJFAQSA-N 0.000 description 2
- PGEFRHBWGOJPJT-KKUMJFAQSA-N Tyr-Lys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O PGEFRHBWGOJPJT-KKUMJFAQSA-N 0.000 description 2
- FWOVTJKVUCGVND-UFYCRDLUSA-N Tyr-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FWOVTJKVUCGVND-UFYCRDLUSA-N 0.000 description 2
- OGPKMBOPMDTEDM-IHRRRGAJSA-N Tyr-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N OGPKMBOPMDTEDM-IHRRRGAJSA-N 0.000 description 2
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 2
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 2
- WYOBRXPIZVKNMF-IRXDYDNUSA-N Tyr-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 WYOBRXPIZVKNMF-IRXDYDNUSA-N 0.000 description 2
- HURRXSNHCCSJHA-AUTRQRHGSA-N Val-Gln-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HURRXSNHCCSJHA-AUTRQRHGSA-N 0.000 description 2
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 2
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 2
- VBTFUDNTMCHPII-UHFFFAOYSA-N Val-Trp-Tyr Natural products C=1NC2=CC=CC=C2C=1CC(NC(=O)C(N)C(C)C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 VBTFUDNTMCHPII-UHFFFAOYSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 101710146545 Venom plasminogen activator Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 101710197154 Zinc metalloproteinase-disintegrin VMP-II Proteins 0.000 description 2
- 101710112278 Zinc metalloproteinase-disintegrin-like Proteins 0.000 description 2
- 101710200352 Zinc metalloproteinase-disintegrin-like VMP-III Proteins 0.000 description 2
- 101710112987 Zinc metalloproteinase-disintegrin-like crotastatin Proteins 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108010077245 asparaginyl-proline Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108010005942 methionylglycine Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 108010079317 prolyl-tyrosine Proteins 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 108010007375 seryl-seryl-seryl-arginine Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 108010058119 tryptophyl-glycyl-glycine Proteins 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- CACCWEPNYHGKGD-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 CACCWEPNYHGKGD-UFLZEWODSA-N 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 101710114512 Acidic phospholipase A2 1 Proteins 0.000 description 1
- 101710114513 Acidic phospholipase A2 2 Proteins 0.000 description 1
- 101710114660 Acidic phospholipase A2 3 Proteins 0.000 description 1
- 101710114661 Acidic phospholipase A2 4 Proteins 0.000 description 1
- 101710114636 Acidic phospholipase A2 5 Proteins 0.000 description 1
- 101710114637 Acidic phospholipase A2 6 Proteins 0.000 description 1
- 101710093374 Acidic phospholipase A2 CM-II Proteins 0.000 description 1
- 101710140191 Acidic phospholipase A2 beta-bungarotoxin A3 chain Proteins 0.000 description 1
- 241000271045 Agkistrodon contortrix contortrix Species 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- YHOPXCAOTRUGLV-XAMCCFCMSA-N Ala-Ala-Asp-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YHOPXCAOTRUGLV-XAMCCFCMSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- UGLPMYSCWHTZQU-AUTRQRHGSA-N Ala-Ala-Tyr Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UGLPMYSCWHTZQU-AUTRQRHGSA-N 0.000 description 1
- DVWVZSJAYIJZFI-FXQIFTODSA-N Ala-Arg-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DVWVZSJAYIJZFI-FXQIFTODSA-N 0.000 description 1
- SSSROGPPPVTHLX-FXQIFTODSA-N Ala-Arg-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSSROGPPPVTHLX-FXQIFTODSA-N 0.000 description 1
- LBJYAILUMSUTAM-ZLUOBGJFSA-N Ala-Asn-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LBJYAILUMSUTAM-ZLUOBGJFSA-N 0.000 description 1
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 1
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 1
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- BVSGPHDECMJBDE-HGNGGELXSA-N Ala-Glu-His Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N BVSGPHDECMJBDE-HGNGGELXSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- CWEAKSWWKHGTRJ-BQBZGAKWSA-N Ala-Gly-Met Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O CWEAKSWWKHGTRJ-BQBZGAKWSA-N 0.000 description 1
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 1
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 1
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 1
- VWVPYNGMOCSSGK-GUBZILKMSA-N Arg-Arg-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O VWVPYNGMOCSSGK-GUBZILKMSA-N 0.000 description 1
- MUXONAMCEUBVGA-DCAQKATOSA-N Arg-Arg-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O MUXONAMCEUBVGA-DCAQKATOSA-N 0.000 description 1
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 1
- MFAMTAVAFBPXDC-LPEHRKFASA-N Arg-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O MFAMTAVAFBPXDC-LPEHRKFASA-N 0.000 description 1
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 1
- LKDHUGLXOHYINY-XUXIUFHCSA-N Arg-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LKDHUGLXOHYINY-XUXIUFHCSA-N 0.000 description 1
- FNXCAFKDGBROCU-STECZYCISA-N Arg-Ile-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FNXCAFKDGBROCU-STECZYCISA-N 0.000 description 1
- LLUGJARLJCGLAR-CYDGBPFRSA-N Arg-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LLUGJARLJCGLAR-CYDGBPFRSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 1
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 1
- LRPZJPMQGKGHSG-XGEHTFHBSA-N Arg-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)O LRPZJPMQGKGHSG-XGEHTFHBSA-N 0.000 description 1
- ZPWMEWYQBWSGAO-ZJDVBMNYSA-N Arg-Thr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZPWMEWYQBWSGAO-ZJDVBMNYSA-N 0.000 description 1
- OGZBJJLRKQZRHL-KJEVXHAQSA-N Arg-Thr-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OGZBJJLRKQZRHL-KJEVXHAQSA-N 0.000 description 1
- NTXNUXPCNRDMAF-WFBYXXMGSA-N Asn-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C)C(O)=O)=CNC2=C1 NTXNUXPCNRDMAF-WFBYXXMGSA-N 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 1
- WVCJSDCHTUTONA-FXQIFTODSA-N Asn-Asp-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WVCJSDCHTUTONA-FXQIFTODSA-N 0.000 description 1
- QISZHYWZHJRDAO-CIUDSAMLSA-N Asn-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N QISZHYWZHJRDAO-CIUDSAMLSA-N 0.000 description 1
- JZRLLSOWDYUKOK-SRVKXCTJSA-N Asn-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N JZRLLSOWDYUKOK-SRVKXCTJSA-N 0.000 description 1
- AYKKKGFJXIDYLX-ACZMJKKPSA-N Asn-Gln-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AYKKKGFJXIDYLX-ACZMJKKPSA-N 0.000 description 1
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 1
- OLISTMZJGQUOGS-GMOBBJLQSA-N Asn-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OLISTMZJGQUOGS-GMOBBJLQSA-N 0.000 description 1
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 1
- COWITDLVHMZSIW-CIUDSAMLSA-N Asn-Lys-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O COWITDLVHMZSIW-CIUDSAMLSA-N 0.000 description 1
- UYRPHDGXHKBZHJ-CIUDSAMLSA-N Asn-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N UYRPHDGXHKBZHJ-CIUDSAMLSA-N 0.000 description 1
- ZVUMKOMKQCANOM-AVGNSLFASA-N Asn-Phe-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZVUMKOMKQCANOM-AVGNSLFASA-N 0.000 description 1
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 1
- BKFXFUPYETWGGA-XVSYOHENSA-N Asn-Phe-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BKFXFUPYETWGGA-XVSYOHENSA-N 0.000 description 1
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 1
- ZNYKKCADEQAZKA-FXQIFTODSA-N Asn-Ser-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O ZNYKKCADEQAZKA-FXQIFTODSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 1
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 1
- YSYTWUMRHSFODC-QWRGUYRKSA-N Asn-Tyr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O YSYTWUMRHSFODC-QWRGUYRKSA-N 0.000 description 1
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 1
- LTDGPJKGJDIBQD-LAEOZQHASA-N Asn-Val-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LTDGPJKGJDIBQD-LAEOZQHASA-N 0.000 description 1
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- BLQBMRNMBAYREH-UWJYBYFXSA-N Asp-Ala-Tyr Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O BLQBMRNMBAYREH-UWJYBYFXSA-N 0.000 description 1
- QHAJMRDEWNAIBQ-FXQIFTODSA-N Asp-Arg-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O QHAJMRDEWNAIBQ-FXQIFTODSA-N 0.000 description 1
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 1
- BUVNWKQBMZLCDW-UGYAYLCHSA-N Asp-Asn-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BUVNWKQBMZLCDW-UGYAYLCHSA-N 0.000 description 1
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 1
- NAPNAGZWHQHZLG-ZLUOBGJFSA-N Asp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N NAPNAGZWHQHZLG-ZLUOBGJFSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 1
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 1
- LDLZOAJRXXBVGF-GMOBBJLQSA-N Asp-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N LDLZOAJRXXBVGF-GMOBBJLQSA-N 0.000 description 1
- RTXQQDVBACBSCW-CFMVVWHZSA-N Asp-Ile-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RTXQQDVBACBSCW-CFMVVWHZSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 1
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- CTWCFPWFIGRAEP-CIUDSAMLSA-N Asp-Lys-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O CTWCFPWFIGRAEP-CIUDSAMLSA-N 0.000 description 1
- LBOVBQONZJRWPV-YUMQZZPRSA-N Asp-Lys-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LBOVBQONZJRWPV-YUMQZZPRSA-N 0.000 description 1
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 1
- VWWAFGHMPWBKEP-GMOBBJLQSA-N Asp-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)N VWWAFGHMPWBKEP-GMOBBJLQSA-N 0.000 description 1
- IDDMGSKZQDEDGA-SRVKXCTJSA-N Asp-Phe-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 IDDMGSKZQDEDGA-SRVKXCTJSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 1
- XXAMCEGRCZQGEM-ZLUOBGJFSA-N Asp-Ser-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O XXAMCEGRCZQGEM-ZLUOBGJFSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 1
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710111474 Basic phospholipase A2 1 Proteins 0.000 description 1
- 101710131133 Basic phospholipase A2 10 Proteins 0.000 description 1
- 101710111473 Basic phospholipase A2 2 Proteins 0.000 description 1
- 101710111472 Basic phospholipase A2 3 Proteins 0.000 description 1
- 101710179841 Basic phospholipase A2 CB1 Proteins 0.000 description 1
- 101710179842 Basic phospholipase A2 CB2 Proteins 0.000 description 1
- 101710153958 Basic phospholipase A2 CM-II Proteins 0.000 description 1
- 101710185664 Basic phospholipase A2 PC17 Proteins 0.000 description 1
- 101710161917 Basic phospholipase A2 beta-bungarotoxin A1 chain Proteins 0.000 description 1
- 101710119492 Basic phospholipase A2 beta-bungarotoxin A2 chain Proteins 0.000 description 1
- 101710168876 Basic phospholipase A2 myotoxin-I Proteins 0.000 description 1
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000168540 Bothrops erythromelas Species 0.000 description 1
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000271037 Crotalinae Species 0.000 description 1
- 241001086114 Crotalus durissus cumanensis Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- PLBJMUUEGBBHRH-ZLUOBGJFSA-N Cys-Ala-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLBJMUUEGBBHRH-ZLUOBGJFSA-N 0.000 description 1
- UDPSLLFHOLGXBY-FXQIFTODSA-N Cys-Glu-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDPSLLFHOLGXBY-FXQIFTODSA-N 0.000 description 1
- WZZGXXNRSZIQFC-VGDYDELISA-N Cys-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CS)N WZZGXXNRSZIQFC-VGDYDELISA-N 0.000 description 1
- OTXLNICGSXPGQF-KBIXCLLPSA-N Cys-Ile-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTXLNICGSXPGQF-KBIXCLLPSA-N 0.000 description 1
- TXCCRYAZQBUCOV-CIUDSAMLSA-N Cys-Pro-Gln Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O TXCCRYAZQBUCOV-CIUDSAMLSA-N 0.000 description 1
- IXPSSIBVVKSOIE-SRVKXCTJSA-N Cys-Ser-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N)O IXPSSIBVVKSOIE-SRVKXCTJSA-N 0.000 description 1
- 101800001224 Disintegrin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LJEPDHWNQXPXMM-NHCYSSNCSA-N Gln-Arg-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O LJEPDHWNQXPXMM-NHCYSSNCSA-N 0.000 description 1
- AAOBFSKXAVIORT-GUBZILKMSA-N Gln-Asn-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O AAOBFSKXAVIORT-GUBZILKMSA-N 0.000 description 1
- SXIJQMBEVYWAQT-GUBZILKMSA-N Gln-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N SXIJQMBEVYWAQT-GUBZILKMSA-N 0.000 description 1
- CITDWMLWXNUQKD-FXQIFTODSA-N Gln-Gln-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CITDWMLWXNUQKD-FXQIFTODSA-N 0.000 description 1
- SNLOOPZHAQDMJG-CIUDSAMLSA-N Gln-Glu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SNLOOPZHAQDMJG-CIUDSAMLSA-N 0.000 description 1
- PXAFHUATEHLECW-GUBZILKMSA-N Gln-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N PXAFHUATEHLECW-GUBZILKMSA-N 0.000 description 1
- XSBGUANSZDGULP-IUCAKERBSA-N Gln-Gly-Lys Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O XSBGUANSZDGULP-IUCAKERBSA-N 0.000 description 1
- MTCXQQINVAFZKW-MNXVOIDGSA-N Gln-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MTCXQQINVAFZKW-MNXVOIDGSA-N 0.000 description 1
- XFAUJGNLHIGXET-AVGNSLFASA-N Gln-Leu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XFAUJGNLHIGXET-AVGNSLFASA-N 0.000 description 1
- HSHCEAUPUPJPTE-JYJNAYRXSA-N Gln-Leu-Tyr Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N HSHCEAUPUPJPTE-JYJNAYRXSA-N 0.000 description 1
- JNENSVNAUWONEZ-GUBZILKMSA-N Gln-Lys-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JNENSVNAUWONEZ-GUBZILKMSA-N 0.000 description 1
- CELXWPDNIGWCJN-WDCWCFNPSA-N Gln-Lys-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CELXWPDNIGWCJN-WDCWCFNPSA-N 0.000 description 1
- QKWBEMCLYTYBNI-GVXVVHGQSA-N Gln-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O QKWBEMCLYTYBNI-GVXVVHGQSA-N 0.000 description 1
- XBWGJWXGUNSZAT-CIUDSAMLSA-N Gln-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N XBWGJWXGUNSZAT-CIUDSAMLSA-N 0.000 description 1
- RWCBJYUPAUTWJD-NHCYSSNCSA-N Gln-Met-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O RWCBJYUPAUTWJD-NHCYSSNCSA-N 0.000 description 1
- DYVMTEWCGAVKSE-HJGDQZAQSA-N Gln-Thr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O DYVMTEWCGAVKSE-HJGDQZAQSA-N 0.000 description 1
- RONJIBWTGKVKFY-HTUGSXCWSA-N Gln-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O RONJIBWTGKVKFY-HTUGSXCWSA-N 0.000 description 1
- WIMVKDYAKRAUCG-IHRRRGAJSA-N Gln-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O WIMVKDYAKRAUCG-IHRRRGAJSA-N 0.000 description 1
- OACPJRQRAHMQEQ-NHCYSSNCSA-N Gln-Val-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OACPJRQRAHMQEQ-NHCYSSNCSA-N 0.000 description 1
- 241000015859 Gloydius shedaoensis Species 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 1
- DIXKFOPPGWKZLY-CIUDSAMLSA-N Glu-Arg-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O DIXKFOPPGWKZLY-CIUDSAMLSA-N 0.000 description 1
- NLKVNZUFDPWPNL-YUMQZZPRSA-N Glu-Arg-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O NLKVNZUFDPWPNL-YUMQZZPRSA-N 0.000 description 1
- YKLNMGJYMNPBCP-ACZMJKKPSA-N Glu-Asn-Asp Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YKLNMGJYMNPBCP-ACZMJKKPSA-N 0.000 description 1
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 1
- PBFGQTGPSKWHJA-QEJZJMRPSA-N Glu-Asp-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PBFGQTGPSKWHJA-QEJZJMRPSA-N 0.000 description 1
- WATXSTJXNBOHKD-LAEOZQHASA-N Glu-Asp-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O WATXSTJXNBOHKD-LAEOZQHASA-N 0.000 description 1
- ZXQPJYWZSFGWJB-AVGNSLFASA-N Glu-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N ZXQPJYWZSFGWJB-AVGNSLFASA-N 0.000 description 1
- XHWLNISLUFEWNS-CIUDSAMLSA-N Glu-Gln-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XHWLNISLUFEWNS-CIUDSAMLSA-N 0.000 description 1
- LVCHEMOPBORRLB-DCAQKATOSA-N Glu-Gln-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O LVCHEMOPBORRLB-DCAQKATOSA-N 0.000 description 1
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 1
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 1
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 1
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- WVTIBGWZUMJBFY-GUBZILKMSA-N Glu-His-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O WVTIBGWZUMJBFY-GUBZILKMSA-N 0.000 description 1
- WDTAKCUOIKHCTB-NKIYYHGXSA-N Glu-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N)O WDTAKCUOIKHCTB-NKIYYHGXSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 1
- YVYVMJNUENBOOL-KBIXCLLPSA-N Glu-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YVYVMJNUENBOOL-KBIXCLLPSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- DNPCBMNFQVTHMA-DCAQKATOSA-N Glu-Leu-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DNPCBMNFQVTHMA-DCAQKATOSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- YGLCLCMAYUYZSG-AVGNSLFASA-N Glu-Lys-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 YGLCLCMAYUYZSG-AVGNSLFASA-N 0.000 description 1
- ZQYZDDXTNQXUJH-CIUDSAMLSA-N Glu-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)N ZQYZDDXTNQXUJH-CIUDSAMLSA-N 0.000 description 1
- TWYFJOHWGCCRIR-DCAQKATOSA-N Glu-Pro-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TWYFJOHWGCCRIR-DCAQKATOSA-N 0.000 description 1
- HLYCMRDRWGSTPZ-CIUDSAMLSA-N Glu-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CS)C(=O)O HLYCMRDRWGSTPZ-CIUDSAMLSA-N 0.000 description 1
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
- TZXOPHFCAATANZ-QEJZJMRPSA-N Glu-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N TZXOPHFCAATANZ-QEJZJMRPSA-N 0.000 description 1
- BDISFWMLMNBTGP-NUMRIWBASA-N Glu-Thr-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O BDISFWMLMNBTGP-NUMRIWBASA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- KCCNSVHJSMMGFS-NRPADANISA-N Glu-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N KCCNSVHJSMMGFS-NRPADANISA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- MZZSCEANQDPJER-ONGXEEELSA-N Gly-Ala-Phe Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MZZSCEANQDPJER-ONGXEEELSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- FMVLWTYYODVFRG-BQBZGAKWSA-N Gly-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN FMVLWTYYODVFRG-BQBZGAKWSA-N 0.000 description 1
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 1
- VIIBEIQMLJEUJG-LAEOZQHASA-N Gly-Ile-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O VIIBEIQMLJEUJG-LAEOZQHASA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- FJWSJWACLMTDMI-WPRPVWTQSA-N Gly-Met-Val Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O FJWSJWACLMTDMI-WPRPVWTQSA-N 0.000 description 1
- VNNRLUNBJSWZPF-ZKWXMUAHSA-N Gly-Ser-Ile Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNNRLUNBJSWZPF-ZKWXMUAHSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- WTUSRDZLLWGYAT-KCTSRDHCSA-N Gly-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN WTUSRDZLLWGYAT-KCTSRDHCSA-N 0.000 description 1
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 1
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 1
- IHDKKJVBLGXLEL-STQMWFEESA-N Gly-Tyr-Met Chemical compound CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(O)=O IHDKKJVBLGXLEL-STQMWFEESA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010018999 Haemorrhage subcutaneous Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- IIVZNQCUUMBBKF-GVXVVHGQSA-N His-Gln-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CN=CN1 IIVZNQCUUMBBKF-GVXVVHGQSA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- JENKOCSDMSVWPY-SRVKXCTJSA-N His-Leu-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O JENKOCSDMSVWPY-SRVKXCTJSA-N 0.000 description 1
- PGXZHYYGOPKYKM-IHRRRGAJSA-N His-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)N)C(=O)N[C@@H](CCCCN)C(=O)O PGXZHYYGOPKYKM-IHRRRGAJSA-N 0.000 description 1
- CCUSLCQWVMWTIS-IXOXFDKPSA-N His-Thr-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O CCUSLCQWVMWTIS-IXOXFDKPSA-N 0.000 description 1
- FRDFAWHTPDKRHG-ULQDDVLXSA-N His-Tyr-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CN=CN1 FRDFAWHTPDKRHG-ULQDDVLXSA-N 0.000 description 1
- CMPHFUWXKBPNRS-WDSOQIARSA-N His-Val-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CNC=N1 CMPHFUWXKBPNRS-WDSOQIARSA-N 0.000 description 1
- 101000591312 Homo sapiens Putative MORF4 family-associated protein 1-like protein UPP Proteins 0.000 description 1
- JRHFQUPIZOYKQP-KBIXCLLPSA-N Ile-Ala-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O JRHFQUPIZOYKQP-KBIXCLLPSA-N 0.000 description 1
- CYHYBSGMHMHKOA-CIQUZCHMSA-N Ile-Ala-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CYHYBSGMHMHKOA-CIQUZCHMSA-N 0.000 description 1
- YOTNPRLPIPHQSB-XUXIUFHCSA-N Ile-Arg-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOTNPRLPIPHQSB-XUXIUFHCSA-N 0.000 description 1
- QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 1
- SCHZQZPYHBWYEQ-PEFMBERDSA-N Ile-Asn-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SCHZQZPYHBWYEQ-PEFMBERDSA-N 0.000 description 1
- FJWYJQRCVNGEAQ-ZPFDUUQYSA-N Ile-Asn-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N FJWYJQRCVNGEAQ-ZPFDUUQYSA-N 0.000 description 1
- PNDMHTTXXPUQJH-RWRJDSDZSA-N Ile-Glu-Thr Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)O PNDMHTTXXPUQJH-RWRJDSDZSA-N 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- JLWLMGADIQFKRD-QSFUFRPTSA-N Ile-His-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CN=CN1 JLWLMGADIQFKRD-QSFUFRPTSA-N 0.000 description 1
- HYLIOBDWPQNLKI-HVTMNAMFSA-N Ile-His-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HYLIOBDWPQNLKI-HVTMNAMFSA-N 0.000 description 1
- AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
- KOPIAUWNLKKELG-SIGLWIIPSA-N Ile-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N KOPIAUWNLKKELG-SIGLWIIPSA-N 0.000 description 1
- APDIECQNNDGFPD-PYJNHQTQSA-N Ile-His-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N APDIECQNNDGFPD-PYJNHQTQSA-N 0.000 description 1
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- PKGGWLOLRLOPGK-XUXIUFHCSA-N Ile-Leu-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PKGGWLOLRLOPGK-XUXIUFHCSA-N 0.000 description 1
- UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 1
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 1
- AKOYRLRUFBZOSP-BJDJZHNGSA-N Ile-Lys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N AKOYRLRUFBZOSP-BJDJZHNGSA-N 0.000 description 1
- WSSGUVAKYCQSCT-XUXIUFHCSA-N Ile-Met-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)N WSSGUVAKYCQSCT-XUXIUFHCSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 1
- QHUREMVLLMNUAX-OSUNSFLBSA-N Ile-Thr-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)N QHUREMVLLMNUAX-OSUNSFLBSA-N 0.000 description 1
- HQLSBZFLOUHQJK-STECZYCISA-N Ile-Tyr-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HQLSBZFLOUHQJK-STECZYCISA-N 0.000 description 1
- NXRNRBOKDBIVKQ-CXTHYWKRSA-N Ile-Tyr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N NXRNRBOKDBIVKQ-CXTHYWKRSA-N 0.000 description 1
- NUEHSWNAFIEBCQ-NAKRPEOUSA-N Ile-Val-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O)N NUEHSWNAFIEBCQ-NAKRPEOUSA-N 0.000 description 1
- RQZFWBLDTBDEOF-RNJOBUHISA-N Ile-Val-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N RQZFWBLDTBDEOF-RNJOBUHISA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 238000010824 Kaplan-Meier survival analysis Methods 0.000 description 1
- 101710148618 Keratin, type II cytoskeletal cochleal Proteins 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- 241000271480 Lachesis muta Species 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 1
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 1
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 1
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 1
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 1
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 1
- HPBCTWSUJOGJSH-MNXVOIDGSA-N Leu-Glu-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HPBCTWSUJOGJSH-MNXVOIDGSA-N 0.000 description 1
- HVJVUYQWFYMGJS-GVXVVHGQSA-N Leu-Glu-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVJVUYQWFYMGJS-GVXVVHGQSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- QPXBPQUGXHURGP-UWVGGRQHSA-N Leu-Gly-Met Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N QPXBPQUGXHURGP-UWVGGRQHSA-N 0.000 description 1
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 1
- UCDHVOALNXENLC-KBPBESRZSA-N Leu-Gly-Tyr Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UCDHVOALNXENLC-KBPBESRZSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- AVEGDIAXTDVBJS-XUXIUFHCSA-N Leu-Ile-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AVEGDIAXTDVBJS-XUXIUFHCSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- JLWZLIQRYCTYBD-IHRRRGAJSA-N Leu-Lys-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JLWZLIQRYCTYBD-IHRRRGAJSA-N 0.000 description 1
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- YUTNOGOMBNYPFH-XUXIUFHCSA-N Leu-Pro-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YUTNOGOMBNYPFH-XUXIUFHCSA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 1
- LINKCQUOMUDLKN-KATARQTJSA-N Leu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N)O LINKCQUOMUDLKN-KATARQTJSA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- WUHBLPVELFTPQK-KKUMJFAQSA-N Leu-Tyr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O WUHBLPVELFTPQK-KKUMJFAQSA-N 0.000 description 1
- OZTZJMUZVAVJGY-BZSNNMDCSA-N Leu-Tyr-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N OZTZJMUZVAVJGY-BZSNNMDCSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- FMFNIDICDKEMOE-XUXIUFHCSA-N Leu-Val-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMFNIDICDKEMOE-XUXIUFHCSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- ZQCVMVCVPFYXHZ-SRVKXCTJSA-N Lys-Asn-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN ZQCVMVCVPFYXHZ-SRVKXCTJSA-N 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- SQXUUGUCGJSWCK-CIUDSAMLSA-N Lys-Asp-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N SQXUUGUCGJSWCK-CIUDSAMLSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 1
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 1
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 1
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 1
- MXMDJEJWERYPMO-XUXIUFHCSA-N Lys-Ile-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MXMDJEJWERYPMO-XUXIUFHCSA-N 0.000 description 1
- KEPWSUPUFAPBRF-DKIMLUQUSA-N Lys-Ile-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KEPWSUPUFAPBRF-DKIMLUQUSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- JQSIGLHQNSZZRL-KKUMJFAQSA-N Lys-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N JQSIGLHQNSZZRL-KKUMJFAQSA-N 0.000 description 1
- ATNKHRAIZCMCCN-BZSNNMDCSA-N Lys-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N ATNKHRAIZCMCCN-BZSNNMDCSA-N 0.000 description 1
- BXPHMHQHYHILBB-BZSNNMDCSA-N Lys-Lys-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BXPHMHQHYHILBB-BZSNNMDCSA-N 0.000 description 1
- VSTNAUBHKQPVJX-IHRRRGAJSA-N Lys-Met-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O VSTNAUBHKQPVJX-IHRRRGAJSA-N 0.000 description 1
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 1
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 1
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 1
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 1
- GVKINWYYLOLEFQ-XIRDDKMYSA-N Lys-Trp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(O)=O GVKINWYYLOLEFQ-XIRDDKMYSA-N 0.000 description 1
- IEIHKHYMBIYQTH-YESZJQIVSA-N Lys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCCN)N)C(=O)O IEIHKHYMBIYQTH-YESZJQIVSA-N 0.000 description 1
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 1
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- 241000598351 Malacothrix coulteri Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- BLIPQDLSCFGUFA-GUBZILKMSA-N Met-Arg-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O BLIPQDLSCFGUFA-GUBZILKMSA-N 0.000 description 1
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 1
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 1
- OHMKUHXCDSCOMT-QXEWZRGKSA-N Met-Asn-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHMKUHXCDSCOMT-QXEWZRGKSA-N 0.000 description 1
- WGBMNLCRYKSWAR-DCAQKATOSA-N Met-Asp-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN WGBMNLCRYKSWAR-DCAQKATOSA-N 0.000 description 1
- MHQXIBRPDKXDGZ-ZFWWWQNUSA-N Met-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MHQXIBRPDKXDGZ-ZFWWWQNUSA-N 0.000 description 1
- RVYDCISQIGHAFC-ZPFDUUQYSA-N Met-Ile-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O RVYDCISQIGHAFC-ZPFDUUQYSA-N 0.000 description 1
- RRIHXWPHQSXHAQ-XUXIUFHCSA-N Met-Ile-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O RRIHXWPHQSXHAQ-XUXIUFHCSA-N 0.000 description 1
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 description 1
- CHDYFPCQVUOJEB-ULQDDVLXSA-N Met-Leu-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CHDYFPCQVUOJEB-ULQDDVLXSA-N 0.000 description 1
- WTHGNAAQXISJHP-AVGNSLFASA-N Met-Lys-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O WTHGNAAQXISJHP-AVGNSLFASA-N 0.000 description 1
- CIDICGYKRUTYLE-FXQIFTODSA-N Met-Ser-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CIDICGYKRUTYLE-FXQIFTODSA-N 0.000 description 1
- ZDJICAUBMUKVEJ-CIUDSAMLSA-N Met-Ser-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O ZDJICAUBMUKVEJ-CIUDSAMLSA-N 0.000 description 1
- QQPMHUCGDRJFQK-RHYQMDGZSA-N Met-Thr-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QQPMHUCGDRJFQK-RHYQMDGZSA-N 0.000 description 1
- XTSBLBXAUIBMLW-KKUMJFAQSA-N Met-Tyr-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N XTSBLBXAUIBMLW-KKUMJFAQSA-N 0.000 description 1
- LIIXIZKVWNYQHB-STECZYCISA-N Met-Tyr-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LIIXIZKVWNYQHB-STECZYCISA-N 0.000 description 1
- 102000004128 Myotubularin Human genes 0.000 description 1
- 108090000697 Myotubularin Proteins 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 241001487815 Ovophis monticola Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- VLZGUAUYZGQKPM-DRZSPHRISA-N Phe-Gln-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VLZGUAUYZGQKPM-DRZSPHRISA-N 0.000 description 1
- CTNODEMQIKCZGQ-JYJNAYRXSA-N Phe-Gln-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 CTNODEMQIKCZGQ-JYJNAYRXSA-N 0.000 description 1
- CSDMCMITJLKBAH-SOUVJXGZSA-N Phe-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O CSDMCMITJLKBAH-SOUVJXGZSA-N 0.000 description 1
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 1
- RORUIHAWOLADSH-HJWJTTGWSA-N Phe-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 RORUIHAWOLADSH-HJWJTTGWSA-N 0.000 description 1
- KXUZHWXENMYOHC-QEJZJMRPSA-N Phe-Leu-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUZHWXENMYOHC-QEJZJMRPSA-N 0.000 description 1
- XMQSOOJRRVEHRO-ULQDDVLXSA-N Phe-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 XMQSOOJRRVEHRO-ULQDDVLXSA-N 0.000 description 1
- INHMISZWLJZQGH-ULQDDVLXSA-N Phe-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 INHMISZWLJZQGH-ULQDDVLXSA-N 0.000 description 1
- JLLJTMHNXQTMCK-UBHSHLNASA-N Phe-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 JLLJTMHNXQTMCK-UBHSHLNASA-N 0.000 description 1
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 1
- HBXAOEBRGLCLIW-AVGNSLFASA-N Phe-Ser-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HBXAOEBRGLCLIW-AVGNSLFASA-N 0.000 description 1
- BONHGTUEEPIMPM-AVGNSLFASA-N Phe-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O BONHGTUEEPIMPM-AVGNSLFASA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- BSTPNLNKHKBONJ-HTUGSXCWSA-N Phe-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O BSTPNLNKHKBONJ-HTUGSXCWSA-N 0.000 description 1
- QTDBZORPVYTRJU-KKXDTOCCSA-N Phe-Tyr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O QTDBZORPVYTRJU-KKXDTOCCSA-N 0.000 description 1
- GCFNFKNPCMBHNT-IRXDYDNUSA-N Phe-Tyr-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)O)N GCFNFKNPCMBHNT-IRXDYDNUSA-N 0.000 description 1
- YUPRIZTWANWWHK-DZKIICNBSA-N Phe-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N YUPRIZTWANWWHK-DZKIICNBSA-N 0.000 description 1
- 101710096328 Phospholipase A2 Proteins 0.000 description 1
- 101710145807 Phospholipase A2 1 Proteins 0.000 description 1
- 101710145816 Phospholipase A2 2 Proteins 0.000 description 1
- 101710145815 Phospholipase A2 3 Proteins 0.000 description 1
- 101710150813 Phospholipase A2 crotoxin basic chain Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 1
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 1
- WECYCNFPGZLOOU-FXQIFTODSA-N Pro-Asn-Cys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O WECYCNFPGZLOOU-FXQIFTODSA-N 0.000 description 1
- SBYVDRLQAGENMY-DCAQKATOSA-N Pro-Asn-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O SBYVDRLQAGENMY-DCAQKATOSA-N 0.000 description 1
- WFHYFCWBLSKEMS-KKUMJFAQSA-N Pro-Glu-Phe Chemical compound N([C@@H](CCC(=O)O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 WFHYFCWBLSKEMS-KKUMJFAQSA-N 0.000 description 1
- HAEGAELAYWSUNC-WPRPVWTQSA-N Pro-Gly-Val Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAEGAELAYWSUNC-WPRPVWTQSA-N 0.000 description 1
- LXLFEIHKWGHJJB-XUXIUFHCSA-N Pro-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 LXLFEIHKWGHJJB-XUXIUFHCSA-N 0.000 description 1
- HFNPOYOKIPGAEI-SRVKXCTJSA-N Pro-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 HFNPOYOKIPGAEI-SRVKXCTJSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- CDGABSWLRMECHC-IHRRRGAJSA-N Pro-Lys-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O CDGABSWLRMECHC-IHRRRGAJSA-N 0.000 description 1
- DWGFLKQSGRUQTI-IHRRRGAJSA-N Pro-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 DWGFLKQSGRUQTI-IHRRRGAJSA-N 0.000 description 1
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 1
- BVRBCQBUNGAWFP-KKUMJFAQSA-N Pro-Tyr-Gln Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O BVRBCQBUNGAWFP-KKUMJFAQSA-N 0.000 description 1
- VDHGTOHMHHQSKG-JYJNAYRXSA-N Pro-Val-Phe Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O VDHGTOHMHHQSKG-JYJNAYRXSA-N 0.000 description 1
- 101710150523 Protein FAM126B Proteins 0.000 description 1
- 102100039199 Protein FAM126B Human genes 0.000 description 1
- 102100031570 Protein PHTF2 Human genes 0.000 description 1
- 101710166306 Protein PHTF2 Proteins 0.000 description 1
- 241000997428 Protobothrops jerdonii Species 0.000 description 1
- 102100034096 Putative MORF4 family-associated protein 1-like protein UPP Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 229940124639 Selective inhibitor Drugs 0.000 description 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 1
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 1
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 1
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 1
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- RFBKULCUBJAQFT-BIIVOSGPSA-N Ser-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CO)N)C(=O)O RFBKULCUBJAQFT-BIIVOSGPSA-N 0.000 description 1
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 1
- UFKPDBLKLOBMRH-XHNCKOQMSA-N Ser-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)C(=O)O UFKPDBLKLOBMRH-XHNCKOQMSA-N 0.000 description 1
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 1
- HBTCFCHYALPXME-HTFCKZLJSA-N Ser-Ile-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HBTCFCHYALPXME-HTFCKZLJSA-N 0.000 description 1
- MOINZPRHJGTCHZ-MMWGEVLESA-N Ser-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N MOINZPRHJGTCHZ-MMWGEVLESA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- JLPMFVAIQHCBDC-CIUDSAMLSA-N Ser-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N JLPMFVAIQHCBDC-CIUDSAMLSA-N 0.000 description 1
- AXVNLRQLPLSIPQ-FXQIFTODSA-N Ser-Met-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N AXVNLRQLPLSIPQ-FXQIFTODSA-N 0.000 description 1
- AXOHAHIUJHCLQR-IHRRRGAJSA-N Ser-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CO)N AXOHAHIUJHCLQR-IHRRRGAJSA-N 0.000 description 1
- KZPRPBLHYMZIMH-MXAVVETBSA-N Ser-Phe-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KZPRPBLHYMZIMH-MXAVVETBSA-N 0.000 description 1
- RWDVVSKYZBNDCO-MELADBBJSA-N Ser-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N)C(=O)O RWDVVSKYZBNDCO-MELADBBJSA-N 0.000 description 1
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 1
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 1
- FLMYSKVSDVHLEW-SVSWQMSJSA-N Ser-Thr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLMYSKVSDVHLEW-SVSWQMSJSA-N 0.000 description 1
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- 102000003667 Serine Endopeptidases Human genes 0.000 description 1
- 108090000083 Serine Endopeptidases Proteins 0.000 description 1
- 102100037628 Serine/threonine-protein kinase 3 Human genes 0.000 description 1
- 101710202847 Serine/threonine-protein kinase 3 Proteins 0.000 description 1
- 208000020452 Snakebite envenomation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- JMZKMSTYXHFYAK-VEVYYDQMSA-N Thr-Arg-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O JMZKMSTYXHFYAK-VEVYYDQMSA-N 0.000 description 1
- XVNZSJIKGJLQLH-RCWTZXSCSA-N Thr-Arg-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N)O XVNZSJIKGJLQLH-RCWTZXSCSA-N 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- LYGKYFKSZTUXGZ-ZDLURKLDSA-N Thr-Cys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(O)=O LYGKYFKSZTUXGZ-ZDLURKLDSA-N 0.000 description 1
- XOTBWOCSLMBGMF-SUSMZKCASA-N Thr-Glu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOTBWOCSLMBGMF-SUSMZKCASA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- YJCVECXVYHZOBK-KNZXXDILSA-N Thr-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H]([C@@H](C)O)N YJCVECXVYHZOBK-KNZXXDILSA-N 0.000 description 1
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- KKPOGALELPLJTL-MEYUZBJRSA-N Thr-Lys-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKPOGALELPLJTL-MEYUZBJRSA-N 0.000 description 1
- OWQKBXKXZFRRQL-XGEHTFHBSA-N Thr-Met-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)O)N)O OWQKBXKXZFRRQL-XGEHTFHBSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- WTMPKZWHRCMMMT-KZVJFYERSA-N Thr-Pro-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WTMPKZWHRCMMMT-KZVJFYERSA-N 0.000 description 1
- NYQIZWROIMIQSL-VEVYYDQMSA-N Thr-Pro-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O NYQIZWROIMIQSL-VEVYYDQMSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
- XGUAUKUYQHBUNY-SWRJLBSHSA-N Thr-Trp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O XGUAUKUYQHBUNY-SWRJLBSHSA-N 0.000 description 1
- JNKAYADBODLPMQ-HSHDSVGOSA-N Thr-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)=CNC2=C1 JNKAYADBODLPMQ-HSHDSVGOSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- VYVBSMCZNHOZGD-RCWTZXSCSA-N Thr-Val-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O VYVBSMCZNHOZGD-RCWTZXSCSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000271576 Trimeresurus albolabris Species 0.000 description 1
- 241001532589 Trimeresurus stejnegeri Species 0.000 description 1
- XNRJFXBORWMIPY-DCPHZVHLSA-N Trp-Ala-Phe Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XNRJFXBORWMIPY-DCPHZVHLSA-N 0.000 description 1
- LAIUAVGWZYTBKN-VHWLVUOQSA-N Trp-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O LAIUAVGWZYTBKN-VHWLVUOQSA-N 0.000 description 1
- DVAAUUVLDFKTAQ-VHWLVUOQSA-N Trp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N DVAAUUVLDFKTAQ-VHWLVUOQSA-N 0.000 description 1
- DVIIYMVCSUQOJG-QEJZJMRPSA-N Trp-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DVIIYMVCSUQOJG-QEJZJMRPSA-N 0.000 description 1
- KBKTUNYBNJWFRL-UBHSHLNASA-N Trp-Ser-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 KBKTUNYBNJWFRL-UBHSHLNASA-N 0.000 description 1
- RNDWCRUOGGQDKN-UBHSHLNASA-N Trp-Ser-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RNDWCRUOGGQDKN-UBHSHLNASA-N 0.000 description 1
- SGQSAIFDESQBRA-IHPCNDPISA-N Trp-Tyr-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SGQSAIFDESQBRA-IHPCNDPISA-N 0.000 description 1
- 108010084754 Tuftsin Proteins 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- CDRYEAWHKJSGAF-BPNCWPANSA-N Tyr-Ala-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O CDRYEAWHKJSGAF-BPNCWPANSA-N 0.000 description 1
- MICSYKFECRFCTJ-IHRRRGAJSA-N Tyr-Arg-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O MICSYKFECRFCTJ-IHRRRGAJSA-N 0.000 description 1
- GFZQWWDXJVGEMW-ULQDDVLXSA-N Tyr-Arg-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GFZQWWDXJVGEMW-ULQDDVLXSA-N 0.000 description 1
- PZXUIGWOEWWFQM-SRVKXCTJSA-N Tyr-Asn-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O PZXUIGWOEWWFQM-SRVKXCTJSA-N 0.000 description 1
- OEVJGIHPQOXYFE-SRVKXCTJSA-N Tyr-Asn-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OEVJGIHPQOXYFE-SRVKXCTJSA-N 0.000 description 1
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 1
- HZZKQZDUIKVFDZ-AVGNSLFASA-N Tyr-Gln-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)O HZZKQZDUIKVFDZ-AVGNSLFASA-N 0.000 description 1
- MPKPIWFFDWVJGC-IRIUXVKKSA-N Tyr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O MPKPIWFFDWVJGC-IRIUXVKKSA-N 0.000 description 1
- NQJDICVXXIMMMB-XDTLVQLUSA-N Tyr-Glu-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O NQJDICVXXIMMMB-XDTLVQLUSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- KZOZXAYPVKKDIO-UFYCRDLUSA-N Tyr-Met-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 KZOZXAYPVKKDIO-UFYCRDLUSA-N 0.000 description 1
- FASACHWGQBNSRO-ZEWNOJEFSA-N Tyr-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FASACHWGQBNSRO-ZEWNOJEFSA-N 0.000 description 1
- YYLHVUCSTXXKBS-IHRRRGAJSA-N Tyr-Pro-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YYLHVUCSTXXKBS-IHRRRGAJSA-N 0.000 description 1
- RGYCVIZZTUBSSG-JYJNAYRXSA-N Tyr-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O RGYCVIZZTUBSSG-JYJNAYRXSA-N 0.000 description 1
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 1
- TYFLVOUZHQUBGM-IHRRRGAJSA-N Tyr-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TYFLVOUZHQUBGM-IHRRRGAJSA-N 0.000 description 1
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 1
- ABZWHLRQBSBPTO-RNXOBYDBSA-N Tyr-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)N ABZWHLRQBSBPTO-RNXOBYDBSA-N 0.000 description 1
- NWEGIYMHTZXVBP-JSGCOSHPSA-N Tyr-Val-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O NWEGIYMHTZXVBP-JSGCOSHPSA-N 0.000 description 1
- RVGVIWNHABGIFH-IHRRRGAJSA-N Tyr-Val-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O RVGVIWNHABGIFH-IHRRRGAJSA-N 0.000 description 1
- 206010045555 Unresponsive to stimuli Diseases 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- UDLYXGYWTVOIKU-QXEWZRGKSA-N Val-Asn-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UDLYXGYWTVOIKU-QXEWZRGKSA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- HZYOWMGWKKRMBZ-BYULHYEWSA-N Val-Asp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HZYOWMGWKKRMBZ-BYULHYEWSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- AGKDVLSDNSTLFA-UMNHJUIQSA-N Val-Gln-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N AGKDVLSDNSTLFA-UMNHJUIQSA-N 0.000 description 1
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- BZMIYHIJVVJPCK-QSFUFRPTSA-N Val-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N BZMIYHIJVVJPCK-QSFUFRPTSA-N 0.000 description 1
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 1
- VHRLUTIMTDOVCG-PEDHHIEDSA-N Val-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](C(C)C)N VHRLUTIMTDOVCG-PEDHHIEDSA-N 0.000 description 1
- FTKXYXACXYOHND-XUXIUFHCSA-N Val-Ile-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O FTKXYXACXYOHND-XUXIUFHCSA-N 0.000 description 1
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- XXWBHOWRARMUOC-NHCYSSNCSA-N Val-Lys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N XXWBHOWRARMUOC-NHCYSSNCSA-N 0.000 description 1
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 1
- CXWJFWAZIVWBOS-XQQFMLRXSA-N Val-Lys-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CXWJFWAZIVWBOS-XQQFMLRXSA-N 0.000 description 1
- RSGHLMMKXJGCMK-JYJNAYRXSA-N Val-Met-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N RSGHLMMKXJGCMK-JYJNAYRXSA-N 0.000 description 1
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 1
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 1
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- CEKSLIVSNNGOKH-KZVJFYERSA-N Val-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C(C)C)N)O CEKSLIVSNNGOKH-KZVJFYERSA-N 0.000 description 1
- USXYVSTVPHELAF-RCWTZXSCSA-N Val-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N)O USXYVSTVPHELAF-RCWTZXSCSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- DOBHJKVVACOQTN-DZKIICNBSA-N Val-Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 DOBHJKVVACOQTN-DZKIICNBSA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010038850 arginyl-isoleucyl-tyrosine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 108010049355 catrocollastatin Proteins 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HPAIKDPJURGQLN-UHFFFAOYSA-N glycyl-L-histidyl-L-phenylalanine Natural products C=1C=CC=CC=1CC(C(O)=O)NC(=O)C(NC(=O)CN)CC1=CN=CN1 HPAIKDPJURGQLN-UHFFFAOYSA-N 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108700023046 methionyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- BSOQXXWZTUDTEL-QAQREVAFSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-QAQREVAFSA-N 0.000 description 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000034614 regulation of DNA-dependent DNA replication initiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 229950009811 ubenimex Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
본 발명은 한국형 살무사과 사독의 항사독 조성물에 관한 것이다. 본 발명의 항사독 조성물을 이용하여 한국형 살무사과 사독에 따른 효과적인 치료가 가능하다.
Description
본 발명은 한국형 살무사과 사독의 항사독 조성물에 관한 것이다.
현재 한국 내에 서식하고 있는 독사로 규정되어 있는 살무사과 뱀은 살무사 (Gloydius brevicaudus), 까치살무사 (Gloydius intermedius) 및 쇠살무사 (Gloydius ussuriensis)와 세계보건기구 (WHO)에서 인정하는 유혈목이를 들 수 있다.
뱀물림 (사교상, snake bite envenomation) 사고는 독성분을 보유한 뱀이 치아를 통해 사람의 피부, 근육, 혈관 등으로 독액을 주입하여 다양한 중독 증상을 보이며, 사독(snake venom)은 종(species)에 따라 성분과 독력, 인체에 미치는 영향 등이 다른 것으로 보고되고 있으나, 최근 국내 발표된 문헌에 근거했을 때 시판되고 있는 수동면역 기반 살무사 (Gloydius brevicaudus)로 만든 항사독소의 경우 환자에게 추가 투여 비율이 높고 중증도도 지속적으로 증가하는 것 (Kang 등, Clin Exp Emerg Med 2016; 3(1): 34-40) 을 볼 때 한국형 살무사과 사독을 해독하는데 중요한 요소가 있는 것으로 판단되고 있었다.
따라서 한국 내 서식하는 살무사과에 해당하는 살무사 3종 살무사(Gloydius brevicaudus), 까치살무사(Gloydius intermedius) 및 쇠살무사(Gloydius ussuriensis))의 사독에 대한 항사독 조성물에 대한 필요성이 대두되었다.
본 발명은 한국형 살무사과 사독의 항사독 조성물을 제공하는 것을 목적으로 한다.
1. 살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
2. 위 1에 있어서, 상기 조성물에 포함되는 혈청은 불활성화한 살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
3. 위 1에 있어서, 메탈로프로테아제 억제제를 더 포함하는. 한국형 살무사과 사독의 항사독 조성물.
4. 까치살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 22 내지 39 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
5. 위 4에 있어서, 상기 혈청은 불활성화한 까치살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
6. 쇠살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 40 내지 57 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
7. 위 6에 있어서, 상기 혈청은 불활성화한 쇠살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
8. 위 6에 있어서, 메탈로프로테아제 억제제를 더 포함하는. 한국형 살무사과 사독의 항사독 조성물.
본 발명의 항사독 조성물을 이용하여 한국형 살무사과 사독에 따른 효과적인 치료가 가능하다.
도 1은 한국 내에 서식하는 살무사, 까치살무사, 쇠살무사의 사독과 표준사독을 전기 영동한 결과이다.
도 2는 한국에 서식하는 살무사 3종에서 획득한 각 사독에 대한 쥐 항체의 단백질체 인식 특성을 비교한 결과이다.
도 3은 까치살무사 사독에 대한 살무사 항사독소와 까치살무사 항사독소 투여시 쥐의 중증도 진행 차이를 비교한 결과이다. * P<0.05 and **<P0.01 vs normal group; #P<0.05 vs Gi or Gi+anti-Gb antisera group (5 h)
도 4는 까치살무사 사독에 대한 살무사 항사독소와 까치살무사 항사독소 투여시의 쥐의 24시간 치사율 개선에 미치는 영향을 비교한 결과이다.
도 5 은 까치살무사 사독에 대한 표준항사독소 또는 까치살무사 항사독소와 투여시의 치사율 저감 약효 평가 결과이다.
도 6은 Matrix metalloprotease (MMPs) 에 대해 선택적인 저해 특성을 갖는 화합물중 독시사이클린 (Doxycycline, CAS ID: 564-25-0, MW: 444.4 g/mol, 시그마알드리치, 미국) (Doxy)에 의한 한국형 살무사 3종 유래 사독에 의한 마우스 피하 출혈에 대한 개선 효과를 확인함으로서 까치 살무사는 다른 한국형 살무사 (살무사, 쇠살무사)와 다른 독력기전을 가짐을 증명한 결과물이다. (A) Saline, (B) Saline+Doxy, (C) 살무사 사독, (D) 살무사 사독 + Doxy, (E) 까치살무사 사독, (F) 까치살무사 사독 + Doxy, (G) 쇠살무사 사독, (H) 쇠살무사 사독 + Doxy.
도 2는 한국에 서식하는 살무사 3종에서 획득한 각 사독에 대한 쥐 항체의 단백질체 인식 특성을 비교한 결과이다.
도 3은 까치살무사 사독에 대한 살무사 항사독소와 까치살무사 항사독소 투여시 쥐의 중증도 진행 차이를 비교한 결과이다. * P<0.05 and **<P0.01 vs normal group; #P<0.05 vs Gi or Gi+anti-Gb antisera group (5 h)
도 4는 까치살무사 사독에 대한 살무사 항사독소와 까치살무사 항사독소 투여시의 쥐의 24시간 치사율 개선에 미치는 영향을 비교한 결과이다.
도 5 은 까치살무사 사독에 대한 표준항사독소 또는 까치살무사 항사독소와 투여시의 치사율 저감 약효 평가 결과이다.
도 6은 Matrix metalloprotease (MMPs) 에 대해 선택적인 저해 특성을 갖는 화합물중 독시사이클린 (Doxycycline, CAS ID: 564-25-0, MW: 444.4 g/mol, 시그마알드리치, 미국) (Doxy)에 의한 한국형 살무사 3종 유래 사독에 의한 마우스 피하 출혈에 대한 개선 효과를 확인함으로서 까치 살무사는 다른 한국형 살무사 (살무사, 쇠살무사)와 다른 독력기전을 가짐을 증명한 결과물이다. (A) Saline, (B) Saline+Doxy, (C) 살무사 사독, (D) 살무사 사독 + Doxy, (E) 까치살무사 사독, (F) 까치살무사 사독 + Doxy, (G) 쇠살무사 사독, (H) 쇠살무사 사독 + Doxy.
이하 본 발명을 상세히 설명한다. 특별한 정의가 없는 한 본 명세서의 모든 용어는 본 발명이 속하는 기술분야의 통상의 지식을 가진 기술자가 이해하는 당해 용어의 일반적인 의미와 동일하고 만약 본 명세서에 사용된 용어의 의미와 충돌하는 경우에는 본 명세서에 사용된 의미를 따른다.
본 발명은 살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고, 혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물에 관한 것이다.
본 발명에 따른 상기 한국형 살무사과 사독의 항사독 조성물은 한국형 살무사과에 해당하는 뱀의 사독에 항사독 효과를 가질 수 있으며, 이에 따라 한국형 살무사과 뱀의 사교상 환자의 치료에 사용될 수 있다.
본 명세서에서 살무사과(Crotalinae)란 오스트레일리아를 제외한 전세계에 널리 분포하는 맹독성 독사를 포함하는 분류학상 과를 말한다.
본 명세서에서 한국형 살무사과는 상기 살무사과 중 분류학상 종으로 분류되는 살무사 (Gloydius brevicaudus), 까치살무사 (Gloydius intermedius), 쇠살무사 (Gloydius ussuriensis)를 포함하는 분류학상 과를 말한다.
본 명세서에서 살무사(Gloydius brevicaudus)는 뱀목 살무사과의 맹독성 파충류를 말한다. 몸 길이는 40 내지 60cm이다. 다 자란 것의 몸은 비교적 짧고 굵은 편이며, 머리는 화살촉 모양에 넓고 꼬리는 짧다. 등쪽은 연한 갈색 또는 회색 바탕에 U자를 거꾸로 쓴 모양의 갈색 무늬가 뚜렷하다. 무늬는 등의 가운데 선을 기준으로 하여 좌우로 쌍을 이루고 서로 붙거나 떨어져 있다. 배쪽은 검정색이거나 이에 가깝고 옆면은 색깔이 연하다. 볼에는 흰색 테두리가 쳐진 짙은 갈색 줄무늬가 입술에서 입아귀까지 이어지며, 볼의 홈은 뚜렷하지 않다. 혀는 검정색이고 꼬리 끝은 연한 노란색이다. 몸 중앙의 비늘줄은 21줄이고, 몸 앞부분의 비늘에는 용골이 없으나 뒷부분의 것은 모두 용골이다. 각 비늘에 1쌍의 작은 비늘구멍이 있는 점이 다른 살무사류와 다르다.
본 명세서에서 사독(Snake venom)이란 독사의 독샘에서 나오는 독을 말한다. 사독의 효과는 교상을 입은 대상의 신체에서 다양한 형태로 나타날 수 있다. 예를 들면, 대상체에서 신경기능을 해칠 수 있고, 대상체에서 모세혈관의 벽을 파괴하여 출혈시키고 적혈구를 파괴해서 용혈작용을 일으킬 수 있으며, 혈액을 응고시키는 등의 형태로 나타날 수 있다.
본 발명에서 사독은 살모사 독일 수 있으며, 상기 살모사 독은 크로탈로톡신(crotalotoxin)이라고도 하며, 혈관벽에 작용해서 출혈을 시키는 한편 독 속에 들어 있는 레시티나아제 A라는 효소에 의해 혈청 속에 있는 레시틴을 분해하고 용혈성이 강한 리조레시틴을 발생시켜 적혈구를 파괴할 수 있다.
본 발명에서 한국형 살무사과 3종의 사독은 서로 다른 단백질 또는 펩타이드를 포함할 수 있다. 따라서 상기 단백질 또는 펩타이드에 따라 항사독소로 이용될 수 있는 항혈청이 달라질 수 있으며, 상기 항사독소는 단백질 또는 펩타이드에 특이적인 항체를 포함할 수 있다.
본 발명에서 상기 혈청은 동물로부터 수득된 시료에서 얻을 수 있다. 상기 시료는 상기 피검체로부터 수득된 것이라면 제한 없이 사용될 수 있다. 예를 들어, 상기 시료는 피검체로부터 수득된 혈액, 타액, 땀 또는 소변 등 일 수 있다.
본 발명에서 상기 혈청은 서열번호 1 내지 21 중 적어도 하나의 펩타이드를 포함할 수 있다.
본 발명에서 상기 서열번호 1 내지 21 중 적어도 하나의 펩타이드는 한국형 살무사과 뱀 중 살무사 독 특이적 펩타이드일 수 있다. 상기 서열번호 1 내지 21 중 적어도 하나의 펩타이드 서열을 포함하는 사독은 살무사 독일 수 있다. 예를 들어, 상기 살무사 독은 서열번호 1 내지 서열번호 21의 펩타이드 서열의 부가, 결실 또는 치환된 서열을 포함하는 펩타이드도 포함할 수 있다.
본 발명 조성물은 혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용일 수 있다. 서열번호 1 내지 21은 살무사 독에 특이적으로 존재하는 펩타이드이다.
본 명세서에서 "교상"이란 짐승, 뱀, 독벌레 등 동물에게 물린 것. 또는 물려서 생긴 상처를 말한다. "사교상"이란 뱀에 의한 교상을 말한다.
본 발명에서 상기 혈청은 불활성화한 살무사 독을 면역항원보강제 (immunological adjuvant)와 함께 주입한 동물로부터 얻어진 것일 수 있다.
본 발명에서 상기 불활성화한 살무사 독은 사독 내에 포함된 단백질 또는 펩타이드가 변성되어 독성이 감소 또는 제거된 사독일 수 있다. 예를 들어, 상기 불활성화는 화학적 또는 물리적인 방법에 의한 것일 수 있다. 구체적으로, 열에 의한 불활성화 일 수 있다.
본 발명에서 상기 면역항원보강제는 면역반응의 조절 (강화, 억제) 활성을 하는 물질을 말하며, 항원의 투여 형태에 대한 방법과 면역담당세포에 작용하여 항원특이적 또는 비특이적으로 면역응답을 증강 또는 억제시킬 수 있다.
본 발명에서 상기 면역항원보강제는 면역반응을 조절할 수 있는 물질이라면 제한 없이 사용될 수 있다. 예를 들어, 균체성분, 그람음성균의 내독소, 합성화합물, 생체성분유래의 단백질 또는 펩타이드성 물질일 수 있다. 더욱 구체적으로, BCG, Propionibacterium acnes 등의 균체, 세포벽, 트레할로오스다이마이코레트(TDM), 리포다당체(LPS)나 리피드A 분획, β-글루칸(다당체), N-아세틸뮤라밀디펩티드(MDP), 베스타틴, 레바미졸, 흉선호르몬, 흉선인자, 타프트신 등일 수 있다.
본 발명에서 동물에 상기 불활성화한 살무사 독과 면역항원보강제를 함께 주입하여, 상기 동물의 체내에서 상기 살무사 독에 특이적인 항사독소를 형성하도록 할 수 있다.
본 발명 조성물은 메탈로프로테아제 억제제를 더 포함할 수 있다. 이는 예를 들면 독시사이클린일 수 있다.
또한, 본 발명은 까치살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고, 상기 혈청에 서열번호 22 내지 39 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물에 관한 것이다.
본 명세서에서 까치살무사(Gloydius intermedius)는 뱀목 살모사과의 맹독성 파충류로, 칠점사라고도 한다. 길이는 50 내지 65cm, 무게는 200 내지 600g로서 한국에 사는 살모사류 가운데 가장 크고 굵다. 머리는 삼각형이며 정수리에 화살모양의 흰 무늬가 있고, 눈과 콧구멍 사이에 홈이 패어 있다. 눈동자는 세로로 선 타원형이고 위턱에 송곳니처럼 생긴 독아가 나 있다. 몸 빛깔은 잿빛을 띤 노란색이며 검은 가로줄무늬가 있고, 배에는 검은 바탕에 흰 대리석무늬가 있다. 몸통 비늘에는 용골돌기가 뚜렷하고 꼬리의 배쪽은 1줄의 비늘로 덮여 있다. 출혈독과 신경독을 함께 가지고 있으며 한국에 사는 살무사과의 뱀 가운데 가장 독성이 강하다.
본 발명에서 상기 서열번호 22 내지 39 중 적어도 하나의 펩타이드는 한국형 살무사과 뱀 중 까치살무사 독 특이적 펩타이드일 수 있다. 상기 서열번호 22 내지 39 중 적어도 하나의 펩타이드 서열을 포함하는 사독은 까치살무사 독일 수 있다. 예를 들어, 상기 까치살무사 독은 서열번호 22 내지 서열번호 39의 펩타이드 서열의 부가, 결실 또는 치환된 서열을 포함하는 펩타이드도 포함할 수 있다.
본 발명 조성물은 혈청에 서열번호 22 내지 39 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용일 수 있다. 서열번호 22 내지 39는 까치살무사 독에 특이적으로 존재하는 펩타이드이다.
본 발명에서 상기 혈청은 불활성화한 까치살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것일 수 있다.
본 발명에서 상기 불활성화한 까치살무사 독은 사독 내에 포함된 단백질 또는 펩타이드가 변성되어 독성이 감소 또는 제거된 사독일 수 있다. 예를 들어, 상기 불활성화는 화학적 또는 물리적인 방법에 의한 것일 수 있다. 구체적으로, 열에 의한 불활성화 일 수 있다.
본 발명에서 동물에 상기 불활성화한 까치살무사 독과 면역항원보강제를 함께 주입하여, 상기 동물의 체내에서 상기 까치살무사 독에 특이적인 항사독소를 형성하도록 할 수 있다.
기타 세부적인 사항은 혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용 조성물에 관한 내용과 같다.
또한, 본 발명은 쇠살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고, 상기 혈청에서 서열번호 40 내지 57 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물에 관한 것이다.
본 명세서에서 쇠살무사(Gloydius ussuriensis)는 뱀목 살무사과에 속하는 맹독성 파충류이다. 몸길이는 61 내지 62.5cm이다. 살무사에 비해 몸이 작고 가늘며, 머리의 너비가 좁고 꼬리는 비교적 길다. 등에는 짙은 회색 또는 짙은 갈색 바탕에 가장자리가 진한 직사각형 무늬가 2개의 비늘줄에 걸쳐 펴져 있다. 볼에는 가는 흰 테두리가 쳐진 갈색 줄무늬가 있다. 혀는 분홍색, 꼬리 끝은 짙은 색이다. 머리 양쪽 옆면에 패인 홈이 뚜렷하지 않고, 등의 뒤쪽 비늘에는 모두 용골이 있다. 주로 물가의 풀밭이나 낮은 언덕에서 살며 난태생이다.
본 발명에서 서열번호 40 내지 57 중 적어도 하나의 펩타이드는 한국형 살무사과 뱀 중 쇠살무사 독 특이적 펩타이드일 수 있다. 상기 서열번호 40 내지 57 중 적어도 하나의 펩타이드를 서열을 포함하는 사독은 쇠살무사 독일 수 있다. 예를 들어, 상기 쇠살무사 독은 서열번호 40 내지 서열번호 57의 펩타이드 서열의 부가, 결실 또는 치환된 서열을 포함하는 펩타이드도 포함할 수 있다.
본 발명 조성물은 혈청에 서열번호 40 내지 57 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용일 수 있다. 서열번호 40 내지 57은 쇠살무사 독에 특이적으로 존재하는 펩타이드이다.
본 발명에서 상기 혈청은 불활성화한 쇠살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것일 수 있다.
본 발명에서 상기 불활성화한 쇠살무사 독은 사독 내에 포함된 단백질 또는 펩타이드가 변성되어 독성이 감소 또는 제거된 사독일 수 있다. 예를 들어, 상기 불활성화는 화학적 또는 물리적인 방법에 의한 것일 수 있다. 구체적으로, 열에 의한 불활성화 일 수 있다.
본 발명에서 동물에 상기 불활성화한 쇠살무사 독과 면역항원보강제를 함께 주입하여, 상기 동물의 체내에서 상기 쇠살무사 독에 특이적인 항사독소를 형성하도록 할 수 있다.
본 발명 조성물은 메탈로프로테아제 억제제를 더 포함할 수 있다. 이는 예를 들면 독시사이클린일 수 있다.
기타 세부적인 사항은 혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용 조성물에 관한 내용과 같다.
본 발명에서 상기 동물은 인간을 포함한 쥐, 래트(rat), 생쥐, 가축 등의 모든 동물일 수 있다. 구체적인 예로, 인간을 포함한 포유동물일 수 있다.
본 발명에서 상기 항사독 조성물은 상기 펩타이드 중 적어도 하나에 결합하는 물질을 포함할 수 있다. 상기 펩타이드에 결합하는 물질은 펩타이드의 표면 또는 내부에 결합할 수 있는 물질이라면 제한되지 않는다. 예를 들어, 상기 물질은 항체일 수 있다.
본 발명에서 상기 물질은 펩타이드의 아미노산 서열 중 일부에 결합하거나 펩타이드의 2차원 이상의 입체적인 구조상 일부에 결합할 수 있다.
상기 결합은 물리적 또는 화학적 결합일 수 있다. 예를 들어, 공유 결합 또는 정전기적 결합일 수 있다.
이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다.
실시예
실시예 1. 한국에서 서식하는 살무사 3종에서의 사독 및 표준사독의 획득
한국에 서식하고 있으며 뱀물림 (교상)으로 인한 독성증상을 유발하는 3종의 살무사 계열의 뱀종인 살무사, 까치살무사, 쇠살무사의 사독을 구별하여 채취하였다.
보호 장구를 착용하고 뱀의 머리 부분을 손으로 속박하여 구개부를 개방시키고 치아를 노출시킨다. 그 후, 멸균된 1회용 플라스틱 용기에 치아 끝을 마찰시켜 사독이 분출되도록 유도하였고 이를 회수하였다. 획득한 사독은 소량씩 분주하여 -80에 즉시 냉동 보관하였고, 사용직전에 해동하여 단백질 농도 등을 측정하였다.
표준사독은 식품의약품 안전처에서 생물의약품 국가표준품 사독 2차 (Snake Venom 2nd 코드번호: MFDS-B-17-002)을 유상 분양받아 사용하였다. 표준사독에는 안정제로서 인 유래 알부민 및 자당을 포함하고 있다.
실시예 2. 사독에 대한 항사독소 (항체) 제작
한국에 서식하고 있는 3종의 살무사로부터 획득한 사독은 사용 직전에 해동하여 멸균된 10% glycerol-phosphate buffered saline (10% glycerol-PBS, pH 7.4)에 적정 비율로 희석하였다. 6주령 웅성마우스 (C57BL/6) 에 complete adjuvant (Sigma-Aldrich, 미국) 와 에멀전화한 열처리 불활성화 사독 혼합물을 동물 1마리당 100μg 의 용량으로 5개 이상의 접종점에 피하주사하였다. 이후 4주가 경과한 후, 매 2주간격으로 incomplete adjuvant 에 에멀전화한 열처리 불활성화 사독 100μg씩 동일한 방법으로 3회 추가 접종하였다. 최종 접종으로부터 2주가 경과한 후에 동물을 에테르로 마취시키고 복부를 절개하여 노출된 간대정맥에서 항응고제를 사용하지 않고 전량 채혈하였다. 적정 응고과정을 거친 후 채혈 혈액으로부터 분리한 혈청은 소분하여 -80℃에 냉동 보관하였고 사용직전에 해동하여 사용하였다. 항체를 포함한 혈청 단백질의 바이오틴 결합은 Pierce 사 (미국) 또는 Sigma-Aldrich 사 (미국)에서 구입한 n-hydroxysuccinamide biotin system 을 이용하여 공급자의 매뉴얼에 따라 실시하였다.
실시예 3. 표준 항사독소 및 종 특이적 항사독소를 이용한 교차 웨스턴블로팅
표준 항사독소는 한국백신에서 판매하는 코박스주(한국백신, 대한민국)를 연구 목적으로 획득하여 사용하였다. 해당 주사제에 포함된 항체는 말로부터 유래된 Fab 부분으로서 PBS로 용해시킨후 단백질 농도를 측정한 후 native electrophoresis를 통해 확인 하였다. IgG를 기준으로 분자량 비율 (IgG: Fab = 120 : 50)을 고려하여 희석배율을 결정하였다.
Bio-rad (미국) 또는 Hoefer 사 (미국)에서 공급받은 전기영동 시스템을 활용하여 sodium dodesyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)를 실시하였다. 분자량 별로 전개된 젤에 위치한 단백질 분포체는 Polyvinylidene fluoride (PVDF) 멤브레인에 transfer 하였고 코박스 또는 뱀 종 특이적 바이오틴 결합 항체를 활용하여 면역 블롯팅을 실시하였다. 면역학적으로 선택적인 신호의 검출을 위해 streptavidin-horseradish peroxidase (HRP)를 반응시키고 Clarity and Clarity Max Western ECL Substrates (Bio-rad, 미국)을 활용하여 LAS-500 mini (GE healthcare, 미국)으로 이미지를 획득하였다 (도 2 참조). 또한 동시에 병렬로 전개한 SDS-PAGE gel 은 Coomassie brilliant blue R-250 염색을 실시하여 단백질 분자량 분포를 비교하였다. (도 1 참조)
실시예 4. 까치살무사 사독을 투여한 동물모델에서 중증도 진행 억제효과 평가
까치살무사 사독 200 μg (50 μl in PBS)을 항살무사 항혈청 또는 까치살무사 항사독소혈청 (50 μl) 과 혼합하여 실온에서 20분간 방치하고, 8주령 웅성 C57BL/6에 대퇴부 근육주사 (100μl) 하였다. 주사가 완료된 시점으로부터 시간별로 중증도의 평가는 (강 등, 대한응급의학회지 27(3), 272-279) 및 Dart 등 (Ann Emerg Med. 1996 Mar;27(3):321-6) 에서 제시한 인체 대상 기준을 바탕으로 0에서 5까지의 score를 적용하여 평가하였다. 0: 정상과 동일한 움직임; 1, 기본활동은 적으나 자극에 대하여 정상적으로 반응하고 정상적으로 움직임; 2. 기본활동이 적고 자극에 대해서 반응하며 비교적 원활하게 움직임; 3. 기본활동이 없고 자극에 대해 반응하며 소극적인 회피 움직임만 보임; 4. 기본활동이 없고 자극에 대해 반응하지 않고 움직이지 않음; 5. 호흡과 심장박동이 없고 사망한 상태. (도 3 참조)
실시예 5. 까치살무사 사독 주입을 항-살무사 혈청 또는 항-까치살무사 혈청과 혼합 투여시의 치사가 감소 약효 평가
(1) 마우스 정상군, 까치살무사 사독 근육 주사군, 까치살무사 사독 + 항-살무사 혈철 근육 주사군, 까치살무사 사독 + 항-까치살무사 혈청 근육 주사군의 중등도 개선 평가를 수행하였다 (김 등, 2018, 살무사 독소 중화항체(항독소) 국가표준품 확립, 식품의약품안전처). 그 결과, 까치살무사 사독 + 항-까치살무사 혈청 근육 주사군의 중등도가 항-살무사 혈청 투여군 대비 개선되어, 해당 살무사 사독에 맞는 혈청이 투여되어야 함을 확인하였다(도 4).
(2) 상기 투여로부터 24시간이 경과한후 생존 동물 수를 센 “치사가”를 평가한 결과는 normal 0%, Gi 83.3%, Gi+항-살무사혈청 66.7%, Gi+항-까치살무사혈청 16.7% (n=3 per group, duplicate)였다(도 4 참조).
실시예 6. 까치살무사 사독을 투여한 동물모델에서 표준 항사독제와 비교하여 까치살무사 항사독소혈청 특이적 생존율 유지효과 평가
까치살무사 사독 90.1μg/mice를 PBS에 희석하여 6주령 웅성 C57BL/6에 복강주사 (100μl) 하였다. 10분이 경과한 뒤 코박스 (표준 항사독제) 또는 까치살무사 항사독소혈청 희석액 (100μl)을 꼬리 정맥에 투여하였다. 생존율은 Kaplan-Meier 생존분석을 통해 평가하였다 (도 5 참조).
실시예 7. 살무사 및 쇠살무사로 인해 유도된 metalloproteinase 에 의한 피하출혈에 선택적 억제제 효능과 까치살무사와의 비교
Metallopretease 억제제로 마우스 대퇴근육부에 주사된 한국형 살무사 3종에 의한 피하 출혈 증상을 개선하는지를 판단하기 위하여 상용화된 제모제를 이용하여 털을 제거하였다. 잔여 물질의 제거를 위해 흐르는 물로 5초 이상 세척하고 자연건조시켰다. 그 후, 사독 (10 μl) 또는 동일 부피의 생리식염수를 단독투여 (피내주사) 한 군과 (도 6 A, C, E, G), 사독과 metalloprotease 억제제인 독시사이클린을 혼합하여 피내 주사한 군에서 (도 6 B, D, F, H) 3시간 후 병변을 관찰하였다.
그 결과는 도 6과 같으며, 독시사이클린 또는 생리식염수 단독투여군은 어떠한 병변도 보이지 않았다. 이에 반해, 살무사 사독 및 쇠살무사 사독 단독 투여군은 피하 출혈이 관찰되었고(도 6C, G), 독시사이클린과 혼합하여 투여한 군에서는 그 발증이 유의하게 감소하는 것을 확인하였다(도 6 D, H). 또한 까치살무사 사독 단독 투여군은 피하 출혈이 전혀 관찰되지 않았는데 이는 까치살무사 사독에는 metalloprotease 함량이 매우 낮으며 독력을 갖는 다른 특성의 단백질의 구성비가 높은 것으로 판단된다. 따라서 대한민국내 뱀교상 환자가 병원 내원시 한국형 살무사에 대한 선택적인 항사독소의 사용은 매우 중요하다.
실시예 8. 액체크로마토그래피 - 미세단백질체질량분석 (LC-Ms/Ms analysis)
분리된 한국에 서식하는 3종의 살무사로부터 획득한 사독을 2차원 전기영동 분석 (2-dimensinal electrophoresis, 2-DE)을 통해 단백질체 분포 특성을 확인하였다. 사독 내에 분포하는 단백질체의 확인은 Coomassie blue G-250 염색을 통해 실시하였고, 육안으로 유의하게 확인이 가능한 spots을 정확히 취하여 분석에 사용하였다.
육안으로 확인되는 염색된 spots 의 단백질 동정을 위해 액체크로마토그래피-미세단백질체질량분석 (LC-Ms/Ms)을 실시하였다. 시료는 한국기초과학연구원 (대전, 대한민국) 또는 세계김치연구소 (광주, 대한민국)에 유상으로 분석서비스를 요청하여 분석하였다.
컬럼상에 고정된 단백질 단편으로부터 용리된 단백질로부터 LC-Ms/Ms에 의해 관찰된 펩티드 패턴을 피크로 도시하였고, 펩티드 서열은 탐색 엔진 마스코트(Mascot)를 이용하여 동정하였다.
그 결과 얻어진 일치도가 높은 단백질의 종류를 열거하였다 (표 1 참조).
Species | ID in gel | Venom protein name | ID |
G. blomhoffii | Gb1 | Metalloprotease [Gloydiushalys] | gi|4106001 |
catrocollastatinprecursor [Crotalusatrox] | gi|710354 | ||
keratin, type II cytoskeletal-like [Protobothropsmucrosquamatus] | gi|1002567295 | ||
Gb2 | L-Amino acid oxidase (M-LAO) [Gloydiusblomhoffii] | gi|15887054 | |
metalloprotease [Gloydiushalys] | gi|4106001 | ||
L-amino acid oxidase, partial [Crotalusdurissuscumanensis] | gi|426205815 | ||
Gb3 | Plasminogen activator precursor [Gloydiusbrevicaudus] | gi|4102926 | |
Chain A, Triflin | gi|71041900 | ||
keratin, type II cytoskeletal 6C-like [Protobothropsmucrosquamatus] | gi|1002567300 | ||
Gb4 | Plasminogen activator precursor [Gloydiusbrevicaudus] | gi|4102927 | |
Serine proteinase 2a [Agkistrodoncontortrixcontortrix] | gi|1180525205 | ||
Keratin, type I cytoskeletal 19 [Crotalusadamanteus] | gi|387016580 | ||
Gb5 | metalloprotease [Gloydiushalys] | gi|4106007 | |
metalloproteinase precursor [Gloydiushalys] | gi|92087833 | ||
keratin, type II cytoskeletal 6A-like [Protobothropsmucrosquamatus] | gi|1002608303 | ||
Gb6 | metalloprotease [Gloydiusbrevicaudus] | gi|14794943 | |
keratin, type II cytoskeletal 6A-like [Protobothropsmucrosquamatus] | gi|1002608303 | ||
Keratin, type II cytoskeletal cochleal-like [Crotalusadamanteus] | gi|387016582 | ||
Gb7 | metalloproteinase, partial [Gloydiusbrevicaudus] | gi|14794943 | |
keratin, type I cytoskeletal 19-like isoform X1 [Protobothropsmucrosquamatus] | gi|1002572370 | ||
unnamed protein product [Agkistrodon piscivorus] | gi|19701420 | ||
Gb8 | Phospholipase A2, partial [Gloydiushalys] | gi|2460033 | |
phospholipase A2 [Trimeresurusalbolabris] | gi|584481280 | ||
histone-lysine N-methyltransferasePRDM9-like [Protobothropsmucrosquamatus] | gi|1002590585 | ||
Gb9 | Fibrinogen clotting inhibitor A chain [Gloydiusbrevicaudus] | gi|4337050 | |
Phospholipase A2, Chain R | gi|230255 | ||
histone-lysine N-methyltransferase PRDM9-like [Protobothropsmucrosquamatus] | gi|1002590585 | ||
Gb10 | Snaclec rhodocetin subunit alpha | gi|3287903 | |
putative homeodomain transcription factor 2 [Protobothropsmucrosquamatus] | gi|1002607626 | ||
histone-lysine N-methyltransferase PRDM9-like [Protobothropsmucrosquamatus] | gi|1002590585 | ||
G. intermedius | Gi1 | Serine protease 1 [Gloydiusintermedius] | gi|1240181215 |
snake venom serine protease 3-like [Protobothropsmucrosquamatus] | gi|1002585669 | ||
DNA replication licensing factor mcm5-like [Crotalushorridus] | gi|743538514 | ||
Gi2 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | |
snake venom serine protease 3-like [Protobothropsmucrosquamatus] | gi|1002585669 | ||
Keratin, type I cytoskeletal 19 [Crotalusadamanteus] | gi|387016580 | ||
Gi3 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | |
snake venom serine protease 3-like [Protobothropsmucrosquamatus] | gi|1002585669 | ||
Keratin, type I cytoskeletal 19 [Crotalusadamanteus] | gi|387016580 | ||
Gi4 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | |
snake venom serine protease 3-like [Protobothropsmucrosquamatus] | gi|1002585669 | ||
serine proteinase 3 [Crotalusadamanteus] | gi|338855336 | ||
Gi5 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | |
snake venom serine protease 3-like [Protobothropsmucrosquamatus] | gi|1002585669 | ||
histone-lysine N-methyltransferase PRDM9-like [Protobothropsmucrosquamatus] | gi|1002590585 | ||
Gi6 | Cystein-rich seceretoryprotein Da-CRPa[Deinagkistrodonacutus] | gi|190195337 | |
Serine proteinase 13g [Agkistrodon piscivorus] | gi|1041577257 | ||
venom plasminogen activator precursor [Trimeresurusstejnegeri] | gi|885976 | ||
Gi7 | Serine protease 13g [Agkistrodon piscivorus] | gi|1041577257 | |
plasminogen activator precursor [Gloydiusbrevicaudus] | gi|4102926 | ||
serine protease [Gloydiusbrevicaudus] | gi|4102924 | ||
Gi8 | Thrombin-like enzyme defibraseb, partial [Gloydiussaxatilis] | gi|31322299 | |
serine proteinase 3 precursor [Protobothropsjerdonii] | gi|9988783 | ||
serine endopeptidase [Crotalusatrox] | gi|1333445278 | ||
Gi9 | vascular endothelial growth factor precursor [Bothropsinsularis] | gi|15072460 | |
acidic phospholipase A2, partial [Gloydiusshedaoensis] | gi|38146948 | ||
keratin, type II cytoskeletal-like [Protobothropsmucrosquamatus] | gi|1002567295 | ||
Gi10 | Phospholipase A2, Chain R | gi|230255 | |
phospholipase A2 [Ovophismonticola] | gi|347516490 | ||
histone-lysine N-methyltransferase PRDM9-like [Protobothropsmucrosquamatus] | gi|1002590585 | ||
G. ussuriensis | Gu1 | vascular apoptosis-inducing protein 2A [Crotalusatrox] | gi|144905068 |
keratin, type II cytoskeletal 6A-like [Protobothropsmucrosquamatus] | gi|1002608303 | ||
Keratin, type I cytoskeletal 18-like protein [Crotalushorridus] | gi|521757830 | ||
Gu2 | keratin, type I cytoskeletal 19-like isoform X1 [Protobothropsmucrosquamatus] | gi|1002572370 | |
keratin, type II cytoskeletal-like [Protobothropsmucrosquamatus] | gi|1002567295 | ||
protein FAM126B [Protobothropsmucrosquamatus] | gi|1002594742 | ||
Gu3 | Keratin, type II cytoskeletal cochleal-like [Crotalusadamanteus] | gi|387016582 | |
metalloproteinase-disintegrin-like protein [Agkistrodon contortrix laticinctus] | gi|2231613 | ||
Snake venom metalloproteinase basparin-A; Short=SVMP | gi|50400289 | ||
Gu4 | metalloproteinase-disintegrin-like protein [Agkistrodon contortrix laticinctus] | gi|2231613 | |
berythractivase[Bothropserythromelas] | gi|17865171 | ||
Keratin, type II cytoskeletal cochleal-like [Crotalusadamanteus] | gi|387016582 | ||
Gu5 | metalloproteinase-disintegrin-like protein [Agkistrodon contortrix laticinctus] | gi|2231613 | |
Snake venom metalloproteinase basparin-A; Short=SVMP | gi|50400289 | ||
disintegrin[Lachesis mutus] | gi|262955 | ||
Gu6 | metalloprotease [Gloydiushalys] | gi|4106007 | |
metalloproteinase precursor [Gloydiushalys] | gi|92087833 | ||
keratin, type I cytoskeletal 19-like isoform X1 [Protobothropsmucrosquamatus] | gi|1002572370 | ||
Gu7 | cysteine-rich seceretoryprotein Bs-CRP [Bothriechisschlegelii] | gi|190195305 | |
metalloprotease [Gloydiushalys] | gi|4106007 | ||
metalloprotease [Gloydiushalys] | gi|4106005 | ||
Gu8 | phospholipase A2, partial [Gloydiushalys] | gi|2460033 | |
Acidic phospholipase A2; Short=svPLA2 | gi|76363284 | ||
serine/threonine-protein kinase 3 [Protobothropsmucrosquamatus] | gi|1002567362 | ||
Gu9 | Neutral phospholipase A2 agkistrodotoxin | gi|129437 | |
N6a basic phospholipase A2 [Sistrurustergeminus] | gi|38230129 | ||
Myotubularin-related protein 1-like protein [Crotalushorridus] | gi|521756789 | ||
Gu10 | Neutral phospholipase A2 agkistrodotoxin | gi|129437 | |
N6a basic phospholipase A2 [Sistrurustergeminus] | gi|38230129 | ||
keratin, type II cytoskeletal-like [Protobothropsmucrosquamatus] | gi|1002567295 |
한국형 살무사 속의 뱀 중 살무사(Gloydius brevicaudus) 와 쇠살무사(Gloydius ussuriensis) 종에서는 metalloprotease 계열의 단백질이 높은 일치도를 갖는 것으로 확인되었으며, 까치살무사(Gloydius saxatilis) 종에서는 serine protease 계열의 단백질이 높은 일치도를 갖는 것으로 확인되었으며, 상기 Mass spectroscopy 상 유의한 피크를 선별하여 확인된 아미노산 서열 분석하였다 (표 2 참조).
Species | ID in gel | Venom protein name | ID | Unique peptides identified |
1G. blomhoffii | Gb1 | Metalloprotease [Gloydiushalys] | gi|4106001 | FVELVLVADKGMVTK(U)* (서열번호 1) TRMYELANNLNDIYR(U)* (서열번호 2) KKHDNAQLLTAIDFNGPTIGYAYIASMCHPK(U)* (서열번호 3) YMYIHVALVGVEIWSDGDKITVTPNVDDTLSSFAEWR(U)* (서열번호 4) MFYSNEDEHKGMVLPGTK |
Gb2 | L-Amino acid oxidase (M-LAO) [Gloydiusblomhoffii] |
gi|15887054 | DVNRASEQ(U)* (서열번호 5) VTVVYQTPAK(U)* (서열번호 6) YPVKPSEEGK(U)* (서열번호 7) AARDVNRASEQ(U)* (서열번호 8) SAGQLYEESLGK(U)* (서열번호 9) |
|
Gb3 | Plasminogen activator precursor [Gloydiusbrevicaudus] | gi|4102926 | VFDHLDWIK(U) KILNEDEQTR(U) NFQMLFGVHSK(U) (서열번호 10) ILNEDEQTRDPK(U) (서열번호 11) DDEKDKDIMLIR(U) (서열번호 12) |
|
Gb4 | Plasminogen activator precursor[Gloydiusbrevicaudus] | gi|4102927 | VFDHLDWIK(U) KILNEDEQTRDPKEK(U) (서열번호 13) NFQMLFGVHSK (서열번호 10) DDEKDKDIMLIR (서열번호 12) |
|
Gb5 | metalloprotease [Gloydiushalys] | gi|4106007 | ETDLLNR(U)* YIELVVVADHGMFTK(U)* YDSNLDTIR(U)* |
|
Gb6 | metalloprotease [Gloydiusbrevicaudus] | gi|14794943 | ERDLLHR(U)* (서열번호 14) YNGDSDKIR(U)* (서열번호 15) GSTGVVQDHSTINLR(U)* (서열번호 16) YIELVIVADHGMFTK(U)* (서열번호 17) IHHDNAMLLTAIDFDGPTIGLAYVGTMCKPK(U)* (서열번호 18) QMVNTVDEIYSYMYIDVALAGLEIWSNEDLINVQPAAPHTLDSFGK(U)* (서열번호 19) |
|
Gb7 | metalloproteinase, partial [Gloydiusbrevicaudus] |
gi|14794943 | ERDLLHR(U)* (서열번호 14) YNGDSDKIR(U)* (서열번호 15) GSTGVVQDHSTINLR(U)* (서열번호 16) YIELVIVADHGMFTK(U)* (서열번호 17) IHHDNAMLLTAIDFDGPTIGLAYVGTMCKPK(U)* (서열번호 18) |
|
Gb8 | Phospholipase A2, partial [Gloydiushalys] | gi|2460033 | SLLQFETLIMKVAKK(U) DNLNTYNDKKYWAFGAK |
|
Gb9 | Fibrinogen clotting inhibitor A chain [Gloydiusbrevicaudus] | gi|4337050 | MTWEDAER(U) (서열번호 19) IETSFPHVWIGLR(U) (서열번호 20) |
|
Gb10 | Snaclecrhodocetinsubunit alpha | gi|3287903 | TWEEAER(U)* (서열번호 21) | |
G. intermedius | Gi1 | Serine protease 1 [Gloydiusintermedius] | gi|1240181215 | KVPNEDEQKR(U)* (서열번호 22) FLVALYHSR(U)* (서열번호 23) VFDHLDWIK(U) VPYPEFGLPATSR(U)* (서열번호 24) |
Gi2 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | LGMHSKK(U)* (서열번호25) KVPNEDEQKR(U)* (서열번호 22) FLVALYHSR(U)* (서열번호 23) VFDHLDWIK(U) SIIAGNTDVSCPP(U) (서열번호 26) VPYPEFGLPATSR(U)* (서열번호 24) |
|
Gi3 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | LGMHSKK(U)* (서열번호 25)KVPNEDEQKR(U)* (서열번호 22) FLVALYHSR(U)* (서열번호 23) VFDHLDWIK(U) VPYPEFGLPATSR(U)* (서열번호 24) |
|
Gi4 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | LGMHSKK(U)* (서열번호 25)KVPNEDEQKR(U)* (서열번호 22) VFDHLDWIK(U) SIIAGNTDVSCPP(U) (서열번호 26) VPYPEFGLPATSR(U)* (서열번호 24) |
|
Gi5 | serine protease 1 [Gloydiusintermedius] | gi|1240181215 | KVPNEDEQKR(U)* (서열번호 22)VFDHLDWIK(U) SIIAGNTDVSCPP(U) (서열번호 26) VPYPEFGLPATSR(U)* (서열번호 24) |
|
Gi6 | Cystein-rich seceretoryprotein Da-CRPa[Deinagkistrodonacutus] | gi|190195337 | SVDFDSESPR(U)* (서열번호 27) CIEEHSSRDSR(U) (서열번호 28) RSVNPTASNMLK* (서열번호 29) MEWYPEAAANAER* (서열번호 30) KPEIQNEIVDLHNSLRR* (서열번호 31) |
|
Gi7 | Serine protease 13g [Agkistrodon piscivorus] | gi|1041577257 | KILNEDEQTRNPKEK(U)* (서열번호 32) DKDIMLIR* |
|
Gi8 | Thrombin-like enzyme defibraseb, partial [Gloydiussaxatilis] | gi|31322299 | KVLNEDEQTRNPKEK(U)* (서열번호 33) KNDEVLDKDIMLIK(U)* (서열번호 34) VSNSEHIVPLSLPSSPPSVGSVCHIMGWGSITPIK(U)* (서열번호 35) LGVHSKK* (서열번호 36) |
|
Gi9 | vascular endothelial growth factor precursor [Bothropsinsularis] |
gi|15072460 | SVGREIMR(U)* (서열번호 37) RNPEEGEPR(U)* (서열번호 38) |
|
Gi10 | Phospholipase A2, Chain R | gi|230255 | SLVQFETLIMK(U)* (서열번호 39) | |
G. ussuriensis | Gu1 | vascular apoptosis-inducing protein 2A [Crotalusatrox] |
gi|144905068 | NNGDLDKIK(U) (서열번호 40) KTDLLTRK(U) (서열번호 41) MYELANTVNDIYR(U) (서열번호 42) MFYSNEDEHKGMVLPGTK(U) |
Gu2 | keratin, type I cytoskeletal 19-like isoform X1 [Protobothropsmucrosquamatus] |
gi|1002572370 | LAADDFR(U) (서열번호 43) VTMQNLNDR(U) (서열번호 44) |
|
Gu3 | Keratin, type II cytoskeletal cochleal-like [Crotalusadamanteus] |
gi|387016582 | NLDLDSIIAEVK(U)* (서열번호 45) FLEQQNK* (서열번호 46) |
|
Gu4 | metalloproteinase-disintegrin-like protein [Agkistrodoncontortrixlaticinctus] | gi|2231613 | ATDLLKRK(U)* (서열번호 47) | |
Gu5 | metalloproteinase-disintegrin-like protein [Agkistrodoncontortrixlaticinctus] | gi|2231613 | ATDLLKR(U) (서열번호 48) | |
Gu6 | metalloprotease [Gloydiushalys] | gi|4106007 | YIELVVVADHGMFTKYDSNLDTIR(U)* (서열번호 49) ETDLLNR* TWVHELVNSINEFYR* (서열번호 50) |
|
Gu7 | cysteine-rich seceretoryprotein Bs-CRP [Bothriechisschlegelii] |
gi|190195305 | DSRVIEGIK(U) (서열번호 51) RSVNPTASNMLK* MEWYPEAAANAER* KPEIQNEIVDLHNSLRR* |
|
Gu8 | phospholipase A2, partial [Gloydiushalys] | gi|2460033 | SLLQFETLIMKVAKK(U) DNLNTYNDKKYWAFGAK |
|
Gu9 | Neutral phospholipase A2 agkistrodotoxin | gi|129437 | NLLQFNK(U)* (서열번호 52) MIKEETGK(U)* (서열번호 53) SDIYSYSLK(U) (서열번호 54) RNLDTYNNGYMFYR(U) (서열번호 55) |
|
Gu10 | Neutral phospholipase A2 agkistrodotoxin | gi|129437 | NLLQFNKMIK(U)* (서열번호 56) MIKEETGK(U)* (서열번호 53) SDIYSYSLK(U) (서열번호 54) RNLDTYNNGYMFYRDSK(U) (서열번호 57) |
|
(U) 표시는 타겟 단백질에서 발견된 특이적 펩타이드(unique peptides)를 나타낸다. * 표시는 샘(gland) mRNA 시퀀싱에서 번역 된 가상의 단백질 라이브러리에서 발견 된 펩티드를 나타낸다. |
실시예 9. mRNA 염기서열을 분석
세 한국형 독사의 사독소 단백질을 코딩할 수 있는 유전자의 염기서열을 분석하기 위하여 사독소가 생산되는 기관으로 추측되는 gland 부위에서 mRNA를 분리하여 next generation sequencing 방법으로 전체 mRNA 염기서열을 분석하였다.
분석된 염기서열 정보를 바탕으로 프라이머를 제작하고 역전사 효소를 이용하여 cDNA를 합성 및 증폭하였다. 증폭된 cDNA는 pGEM-T easy vector에 클로닝하였고 전체 염기서열을 확인하였으며 해당 유전자에서 발현될 단백질 아미노산 서열을 분석하였다. 클로닝된 유전자들은 앞서 2D-gel/MS 분석에서 얻어진 각 단백질들이 포함하는 고유한 펩타이드 서열을 포함하고 있음을 확인하였다 (표 3 참조, 볼드 및 밑줄).
DNA and deduced protein sequences | |
Gb2 | MSANVQVMFSLLFLAALGSCANDRNPLEECFRETDYEEFLEIARNGLKATSNPKHVVVVGAGMSGLSAAYVLSGAGHQVTVLEASERAGGRVRTYRNDKEDWYANLGPMRLPEKHRIVREYIRKFGLQLNEFSQENDNAWYFIKNIRKRVGEVKKDPGVLK YPVKPSEEGKSAGQLYEESLGK VVEELKRTNCSYILNKYDTYSTKEYLLKEGNLSPGAVDMIGDLMNEDSGYYVSFPESLRHDDIFAYEKRFDEIVGGMDKLPTSMYRAIEEKVHLNAQVIKIQKNAEK VTVVYQTPAK EMASVTADYVIVCTTSRATRRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDEGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPREEIQTFCYPSMIQKWSLDKYAMGGITTFTPYQFQHFSESLTASVDRIYFAGEHTAEAHGWIDSTIKSGLR AARDVNRASEQ * (서열번호58) |
ATGTCAGCAAATGTTCAGGTTATGTTCTCACTGCTGTTCTTGGCTGCCTTGGGAAGCTGTGCAAATGACAGAAACCCCCTAGAGGAATGCTTCCGAGAAACTGACTATGAAGAATTTCTAGAGATCGCCAGAAATGGTCTGAAAGCGACATCAAACCCAAAACATGTTGTGGTTGTAGGTGCAGGAATGTCTGGGCTTAGTGCAGCCTATGTTCTTTCAGGGGCTGGACATCAGGTGACAGTTCTTGAAGCCAGTGAACGTGCGGGAGGACGAGTGAGGACTTATCGAAATGACAAAGAAGACTGGTATGCCAATCTCGGGCCCATGCGTTTACCTGAGAAACACAGGATTGTCCGGGAATATATCAGAAAGTTTGGTCTGCAGTTGAATGAATTTTCTCAGGAAAATGACAATGCCTGGTATTTTATCAAAAACATCAGGAAGAGAGTAGGGGAAGTCAAGAAAGACCCTGGCGTCTTGAAATATCCCGTGAAGCCTTCAGAAGAAGGCAAAAGTGCTGGACAGCTATATGAAGAGTCCCTCGGAAAGGTTGTAGAAGAATTAAAAAGGACTAACTGCAGCTACATACTAAATAAATATGACACCTACTCAACGAAGGAGTATCTACTTAAAGAAGGAAATCTGAGTCCTGGAGCTGTAGATATGATTGGAGACTTAATGAATGAAGATTCTGGCTATTATGTGTCTTTTCCTGAAAGCCTGAGACATGATGATATCTTTGCTTATGAAAAAAGATTTGATGAAATTGTTGGTGGAATGGATAAGTTGCCTACATCCATGTATCGAGCCATTGAGGAAAAGGTGCATTTGAATGCCCAAGTAATCAAGATACAGAAGAATGCCGAGAAAGTCACAGTGGTATATCAAACCCCAGCAAAGGAGATGGCATCTGTGACAGCTGATTATGTCATTGTGTGCACTACATCAAGGGCCACCCGTCGCATCAAGTTTGAACCACCCCTTCCGCCAAAGAAAGCGCATGCTTTGCGGTCTGTCCACTACAGAAGTGGCACCAAGATCTTCCTCACTTGCACTAAGAAATTTTGGGAGGATGAAGGCATTCATGGTGGGAAGTCCACAACTGATCTTCCATCCCGATTCATCTACTACCCTAACCATAACTTTACTAGTGGAGTTGGGGTTATTATAGCCTATGGCATTGGTGATGATGCCAATTTCTTTCAAGCTCTTGATTTCAAGGACTGTGCTGATATTGTCATTAATGACCTTTCATTGATCCATCAGCTGCCTAGGGAAGAGATCCAGACCTTCTGTTATCCCTCAATGATTCAAAAATGGAGCCTGGATAAGTATGCTATGGGTGGTATAACCACCTTCACTCCCTACCAGTTTCAACATTTTAGTGAATCGCTCACTGCATCTGTAGACAGAATCTATTTTGCAGGGGAGCATACGGCCGAAGCTCATGGTTGGATTGACAGCACAATTAAGTCAGGGCTGAGAGCAGCAAGAGATGTGAATCGTGCTTCTGAGCAATGA (서열번호59) | |
Gb3 | MIVFIVLPILAAVLQQSSG NVDFDSESPR KPEIQNEIVDLHNSLRRSVNPTASNMLKMEWYPEAAANAEHWAYRCIEDHSSRDSRVLEGIKCGENIYMSSIPMKWTDIIHIWHDEYKNFKYGIGADPPNAVIGHFTQIVWYKSYRAGCAAAYCPSSEYSYFYVCQYCPAGNMRGKTATPYTSGPPCGDCPSACDNGLCTNPCTQEDLFTNCNSLVQQSSCQDNYIKTNCPASCFCHNEIK* (서열번호60) |
ATGATTGTCTTCATTGTCTTGCCAATTCTTGCTGCAGTGCTGCAACAGTCTTCTGGAAATGTTGATTTTGATTCTGAGTCACCCAGGAAACCAGAAATACAAAACGAGATTGTTGACTTGCACAATTCTTTAAGGAGATCTGTGAATCCAACTGCTAGCAACATGCTAAAAATGGAATGGTATCCTGAAGCTGCTGCTAATGCAGAACATTGGGCGTACAGATGTATTGAGGATCACAGTTCACGCGATTCAAGAGTTCTTGAAGGAATAAAATGTGGTGAAAATATATATATGTCATCTATTCCTATGAAATGGACTGACATTATTCACATTTGGCATGATGAATACAAAAATTTCAAGTATGGCATTGGAGCAGACCCACCAAATGCTGTTATTGGCCATTTCACTCAGATAGTTTGGTACAAAAGTTACCGTGCTGGTTGTGCTGCTGCCTATTGTCCTTCATCGGAATACAGCTACTTCTATGTTTGTCAGTACTGCCCAGCAGGAAACATGAGAGGTAAAACTGCTACTCCATATACATCAGGGCCACCTTGTGGGGATTGTCCTTCGGCTTGTGACAATGGACTATGCACAAATCCTTGCACACAAGAAGATCTGTTCACGAACTGCAATAGCTTGGTCCAACAAAGTAGCTGCCAGGATAATTATATAAAGACAAATTGCCCTGCTTCTTGCTTCTGCCACAATGAAATAAAATAG (서열번호61) | |
Gi6 | MIVFIVLPILAAVLQQSSG SVDFDSESPRKPEIQNEIVDLHNSLRRSVNPTASNMLKMEWYPEAAANAER WAYRCIEDHSSRDSRVLEGIKCGENIYMSTIPMKWTDIIHAWHDEYKNFKYGIGADPPNAVIGHYTQIVWYKSYRAGCAAAYCPSSEYSYFYVCQYCPAGNIRGKTATPYTSGPPCGDCPSACDNGLCTNPCTQEDVYTNCNSMVQQSSCQDNYIKTNCPASCFCHNEIK* (서열번호62) |
ATGATTGTCTTCATTGTCTTGCCAATTCTTGCTGCAGTGCTGCAACAGTCTTCTGGAAGTGTTGATTTTGATTCTGAGTCACCCAGGAAACCAGAAATACAAAACGAGATTGTTGACTTGCACAATTCTTTAAGGAGATCTGTGAATCCAACTGCTAGCAACATGCTAAAAATGGAATGGTATCCTGAAGCTGCTGCTAATGCAGAACGTTGGGCGTACAGATGTATTGAGGATCACAGTTCACGCGATTCAAGAGTTCTTGAAGGAATAAAATGTGGTGAAAATATATATATGTCAACTATTCCTATGAAATGGACTGACATTATTCACGCTTGGCATGATGAATACAAAAATTTCAAGTATGGCATTGGAGCAGACCCACCAAATGCTGTTATTGGCCATTACACTCAGATAGTTTGGTACAAAAGTTACCGTGCTGGTTGTGCTGCTGCCTATTGTCCTTCATCGGAATACAGCTACTTCTATGTTTGTCAGTACTGCCCAGCAGGAAACATCAGAGGTAAAACTGCTACTCCATATACATCAGGGCCACCTTGTGGGGATTGTCCTTCGGCTTGTGACAATGGACTATGCACAAATCCTTGCACACAAGAAGATGTGTACACGAACTGCAATAGCATGGTCCAACAAAGTAGCTGCCAGGATAATTATATAAAGACAAATTGCCCTGCTTCTTGCTTCTGCCACAATGAAATAAAATAG (서열번호63) | |
Gu3 | MSQLTSFSSRSATAPSNFSQVRISSVSSSRGIRGSGSFRKPGAFASTSLYNLGSSSRRIASSFPVSPSLGYGGGIQEVTINQNLLSPLNLEIDPTIQKVRKEEKEQIKVLNNKFASFIDKVR FLEQQNK MLETKWNILQQQKTSTRNNTAPVFDAYINNLRRQLDSLQNDKGRLEGELKNMQDLVEDFKNKYEDEINKRTTAENDFVVLKKDVDASYMNKVELEARVDGLTDEINFLRALYEAELAELQNQVSDTSVILQMDNNR NLDLDSIIAEVK AQYEEIANKSRKEAESWYQSKFEALQATAGKHGDDLRSTRNEIAEINRLILRLQAEIDHVKNQRVKLEDAIAEAEERGTLAVKDAKAKLEELEVAMNKAKQEMALQLREYHELMNVKLALDIEIATYRKLLEGEESRLSGDGAGSVSMTLVSSGGGSGGGAYSSGSGLGYGGGFTLGSGMGSGALGFTSGVGSGSLKSTYSVTSTSRRSMRN* (서열번호64) |
ATGTCGCAGCTGACTTCATTCAGTTCTCGTTCAGCAACTGCCCCTTCTAACTTTTCCCAAGTCCGGATCAGCTCTGTTTCTTCATCGCGTGGAATCAGAGGGAGTGGAAGTTTTAGGAAGCCAGGTGCCTTTGCTAGCACCAGTTTGTATAACTTGGGCTCCAGCAGCAGGAGGATTGCCTCGTCTTTCCCTGTCTCACCTTCGCTTGGATATGGCGGTGGTATTCAAGAAGTCACTATTAATCAGAATCTCTTGTCCCCACTCAACCTGGAAATTGACCCAACCATCCAGAAGGTGCGCAAGGAGGAGAAGGAGCAGATTAAGGTCCTCAACAACAAATTTGCATCCTTCATTGACAAGGTCCGATTCCTTGAGCAGCAAAATAAAATGCTGGAGACCAAATGGAACATCTTACAGCAGCAAAAGACCAGCACTCGGAACAACACTGCACCCGTCTTTGACGCGTACATTAACAACCTGCGGAGACAGCTAGACAGCTTGCAGAATGACAAGGGACGGCTGGAAGGAGAACTGAAGAACATGCAGGATCTTGTTGAGGATTTTAAGAACAAGTATGAAGATGAAATCAACAAGCGCACCACTGCAGAGAATGATTTTGTTGTGCTCAAAAAAGATGTTGATGCTTCCTACATGAATAAGGTGGAGCTGGAAGCCAGAGTGGATGGGCTGACAGATGAAATAAATTTCCTGAGAGCGCTTTATGAAGCAGAACTGGCTGAATTGCAGAACCAGGTCTCTGATACATCTGTTATCCTCCAAATGGACAACAATCGGAATCTGGACTTGGACAGTATCATTGCTGAGGTCAAAGCTCAGTATGAGGAGATTGCTAATAAGAGCAGGAAGGAGGCAGAAAGCTGGTACCAAAGCAAGTTTGAGGCCTTGCAAGCCACTGCTGGAAAGCATGGAGATGACCTGCGGAGCACAAGGAATGAGATTGCAGAGATTAATCGCCTAATATTGAGGCTGCAAGCTGAGATTGACCATGTGAAAAACCAGCGTGTCAAGCTTGAAGATGCCATTGCTGAAGCAGAAGAACGCGGTACGTTGGCTGTCAAAGATGCCAAGGCGAAACTAGAGGAGCTGGAGGTGGCCATGAACAAAGCTAAGCAAGAGATGGCCCTCCAGCTGCGTGAATATCACGAGCTGATGAATGTCAAGCTGGCTCTGGATATTGAGATTGCTACTTACAGAAAGCTGCTGGAAGGAGAAGAGAGCAGATTGTCTGGAGACGGAGCTGGTTCTGTAAGCATGACCCTGGTCAGCTCCGGTGGTGGTAGTGGTGGTGGTGCATACAGCAGCGGAAGTGGTCTTGGCTATGGTGGAGGATTTACTCTGGGAAGTGGAATGGGCAGCGGAGCCCTCGGTTTCACCTCTGGAGTTGGCTCAGGCAGCCTGAAATCGACATACAGTGTGACAAGCACATCCAGGAGAAGCATGAGAAATTGAG (서열번호65) | |
Gu8 | MRTLWIMAVLLLGVEGSLIQFETLIMKVAKKSGMFWYNNYGCYCGWGGQ GRPQDATDR CCFVHDCCYGKVTGCDPKMDVYSFSEENGDIVCGGDDPCKKEICECDRAAAICFR DNLNTYNDKKYWAFGAK NCPQEESEPC* (서열번호66) |
ATGAGGACTCTCTGGATAATGGCCGTGTTGCTGCTGGGCGTCGAGGGGAGCCTGATTCAATTTGAGACCCTGATCATGAAAGTGGCGAAGAAAAGTGGTATGTTTTGGTACAACAATTATGGATGCTACTGCGGCTGGGGGGGCCAAGGCCGGCCACAGGACGCCACTGACCGCTGCTGCTTTGTGCATGACTGCTGTTACGGAAAAGTGACCGGCTGTGACCCCAAAATGGACGTCTATTCCTTCAGCGAGGAGAACGGGGATATTGTCTGCGGAGGGGACGACCCGTGCAAGAAGGAGATTTGTGAGTGCGATAGGGCCGCGGCAATCTGCTTCCGAGACAATCTGAACACATACAATGACAAAAAATATTGGGCGTTCGGGGCCAAAAATTGCCCGCAGGAGGAGTCAGAGCCATGTTAA (서열번호67) | |
Gu9 | MRTLWIMAVLLLGVEG NLLQFNKMIKEETGK NAIPFYAFYGCYCGWGGQGKPKDGTDRCCFVHDCCYGRLPNCNTK WDIYSYSLK DGYITCGKGTWCEEQICECDRVAAECFRRNLNTYNNGYMFYRDSKCTETSEEC* (서열번호68) |
ATGAGGACTCTCTGGATAATGGCCGTGTTGCTGCTGGGCGTCGAGGGGAACCTGCTGCAATTCAACAAGATGATCAAGGAAGAGACGGGGAAAAACGCTATTCCCTTCTATGCCTTTTACGGCTGCTACTGTGGCTGGGGGGGCCAAGGCAAGCCAAAGGACGGCACAGACCGCTGCTGCTTTGTGCACGACTGCTGTTACGGAAGACTGCCCAACTGCAACACCAAATGGGACATCTATTCCTACAGCTTGAAGGATGGGTATATCACCTGCGGAAAGGGCACCTGGTGCGAGGAACAGATTTGTGAGTGCGACAGGGTCGCGGCAGAATGCTTCAGAAGGAATCTGAACACGTACAATAATGGATATATGTTTTACCGGGACTCAAAATGCACGGAGACTTCAGAGGAATGCTAA (서열번호69) |
전체 염기서열을 Blast 검색했을 때, 기존에 알려진 유전자와 높은 유사성을 나타내었으나 완전히 일치하는 유전자는 발견되지 않았다 (표 4 참조).
Venom protein name | Per. Ident | Accession | ||
G. blomhoffii | Gb2 | M-LAO [Agkistrodon blomhoffi] | 99.40% | AB072392.1 |
Gb3 | Ablomin [Agkistrodon blomhoffi] | 99.03% | AF384218.1 | |
Gb9 | Acidic phospholipase A2 isoform b [Gloydius strauchi] | 98.32% | MF410701.1 | |
G. intermedius | Gi1 | Venom plasminogen activator precursor 1 [Gloydius intermedius] | 99.22% | KY129939.1 |
Gi6 | Ablomin [Agkistrodon blomhoffi] | 98.34% | AF384218.1 | |
Gi9 | Acidic phospholipase A2 isoform b [Gloydius intermedius] | 99.05% | KJ654338.1 | |
G. ussuriensis | Gu3 | Keratin, type II cytoskeletal cochleal [Protobothrops mucrosquamatus] | 96.67% | XM_015821914.1 |
Gu8 | Acidic phospholipase A2 isoform a [Gloydius strauchi] | 92.43% | MF410700.1 | |
Gu9 | Basic phospholipase A2 [Gloydius intermedius] | 94.26% | KJ654336.1 |
<110> INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
CHONNAM NATIONAL UNIVERSITY HOSPITAL
<120> Composition of anti-venom of the Korean salmosa species' venom
<130> 21P06018
<160> 75
<170> KoPatentIn 3.0
<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 1
Phe Val Glu Leu Val Leu Val Ala Asp Lys Gly Met Val Thr Lys
1 5 10 15
<210> 2
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 2
Thr Arg Met Tyr Glu Leu Ala Asn Asn Leu Asn Asp Ile Tyr Arg
1 5 10 15
<210> 3
<211> 31
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 3
Lys Lys His Asp Asn Ala Gln Leu Leu Thr Ala Ile Asp Phe Asn Gly
1 5 10 15
Pro Thr Ile Gly Tyr Ala Tyr Ile Ala Ser Met Cys His Pro Lys
20 25 30
<210> 4
<211> 37
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 4
Tyr Met Tyr Ile His Val Ala Leu Val Gly Val Glu Ile Trp Ser Asp
1 5 10 15
Gly Asp Lys Ile Thr Val Thr Pro Asn Val Asp Asp Thr Leu Ser Ser
20 25 30
Phe Ala Glu Trp Arg
35
<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 5
Asp Val Asn Arg Ala Ser Glu Gln
1 5
<210> 6
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 6
Val Thr Val Val Tyr Gln Thr Pro Ala Lys
1 5 10
<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 7
Tyr Pro Val Lys Pro Ser Glu Glu Gly Lys
1 5 10
<210> 8
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 8
Ala Ala Arg Asp Val Asn Arg Ala Ser Glu Gln
1 5 10
<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 9
Ser Ala Gly Gln Leu Tyr Glu Glu Ser Leu Gly Lys
1 5 10
<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 10
Asn Phe Gln Met Leu Phe Gly Val His Ser Lys
1 5 10
<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 11
Ile Leu Asn Glu Asp Glu Gln Thr Arg Asp Pro Lys
1 5 10
<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 12
Asp Asp Glu Lys Asp Lys Asp Ile Met Leu Ile Arg
1 5 10
<210> 13
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 13
Lys Ile Leu Asn Glu Asp Glu Gln Thr Arg Asp Pro Lys Glu Lys
1 5 10 15
<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 14
Glu Arg Asp Leu Leu His Arg
1 5
<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 15
Tyr Asn Gly Asp Ser Asp Lys Ile Arg
1 5
<210> 16
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 16
Gly Ser Thr Gly Val Val Gln Asp His Ser Thr Ile Asn Leu Arg
1 5 10 15
<210> 17
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 17
Tyr Ile Glu Leu Val Ile Val Ala Asp His Gly Met Phe Thr Lys
1 5 10 15
<210> 18
<211> 31
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 18
Ile His His Asp Asn Ala Met Leu Leu Thr Ala Ile Asp Phe Asp Gly
1 5 10 15
Pro Thr Ile Gly Leu Ala Tyr Val Gly Thr Met Cys Lys Pro Lys
20 25 30
<210> 19
<211> 46
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 19
Gln Met Val Asn Thr Val Asp Glu Ile Tyr Ser Tyr Met Tyr Ile Asp
1 5 10 15
Val Ala Leu Ala Gly Leu Glu Ile Trp Ser Asn Glu Asp Leu Ile Asn
20 25 30
Val Gln Pro Ala Ala Pro His Thr Leu Asp Ser Phe Gly Lys
35 40 45
<210> 20
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 20
Ile Glu Thr Ser Phe Pro His Val Trp Ile Gly Leu Arg
1 5 10
<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 21
Thr Trp Glu Glu Ala Glu Arg
1 5
<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 22
Lys Val Pro Asn Glu Asp Glu Gln Lys Arg
1 5 10
<210> 23
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 23
Phe Leu Val Ala Leu Tyr His Ser Arg
1 5
<210> 24
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 24
Val Pro Tyr Pro Glu Phe Gly Leu Pro Ala Thr Ser Arg
1 5 10
<210> 25
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 25
Leu Gly Met His Ser Lys Lys
1 5
<210> 26
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 26
Ser Ile Ile Ala Gly Asn Thr Asp Val Ser Cys Pro Pro
1 5 10
<210> 27
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 27
Ser Val Asp Phe Asp Ser Glu Ser Pro Arg
1 5 10
<210> 28
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 28
Cys Ile Glu Glu His Ser Ser Arg Asp Ser Arg
1 5 10
<210> 29
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 29
Arg Ser Val Asn Pro Thr Ala Ser Asn Met Leu Lys
1 5 10
<210> 30
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 30
Met Glu Trp Tyr Pro Glu Ala Ala Ala Asn Ala Glu Arg
1 5 10
<210> 31
<211> 17
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 31
Lys Pro Glu Ile Gln Asn Glu Ile Val Asp Leu His Asn Ser Leu Arg
1 5 10 15
Arg
<210> 32
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 32
Lys Ile Leu Asn Glu Asp Glu Gln Thr Arg Asn Pro Lys Glu Lys
1 5 10 15
<210> 33
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 33
Lys Val Leu Asn Glu Asp Glu Gln Thr Arg Asn Pro Lys Glu Lys
1 5 10 15
<210> 34
<211> 14
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 34
Lys Asn Asp Glu Val Leu Asp Lys Asp Ile Met Leu Ile Lys
1 5 10
<210> 35
<211> 35
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 35
Val Ser Asn Ser Glu His Ile Val Pro Leu Ser Leu Pro Ser Ser Pro
1 5 10 15
Pro Ser Val Gly Ser Val Cys His Ile Met Gly Trp Gly Ser Ile Thr
20 25 30
Pro Ile Lys
35
<210> 36
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 36
Leu Gly Val His Ser Lys Lys
1 5
<210> 37
<211> 16
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 37
Asp Asn Ile Asp Thr Tyr Asp Asn Lys Tyr Trp Phe Phe Pro Ala Lys
1 5 10 15
<210> 38
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 38
Ser Leu Val Gln Phe Glu Thr Leu Ile Met Lys Ile Ala Gly Arg
1 5 10 15
<210> 39
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 39
Ser Val Gly Arg Glu Ile Met Arg
1 5
<210> 40
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 40
Arg Asn Pro Glu Glu Gly Glu Pro Arg
1 5
<210> 41
<211> 11
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 41
Ser Leu Val Gln Phe Glu Thr Leu Ile Met Lys
1 5 10
<210> 42
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 42
Asn Asn Gly Asp Leu Asp Lys Ile Lys
1 5
<210> 43
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 43
Lys Thr Asp Leu Leu Thr Arg Lys
1 5
<210> 44
<211> 13
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 44
Met Tyr Glu Leu Ala Asn Thr Val Asn Asp Ile Tyr Arg
1 5 10
<210> 45
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 45
Leu Ala Ala Asp Asp Phe Arg
1 5
<210> 46
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 46
Val Thr Met Gln Asn Leu Asn Asp Arg
1 5
<210> 47
<211> 12
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 47
Asn Leu Asp Leu Asp Ser Ile Ile Ala Glu Val Lys
1 5 10
<210> 48
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 48
Phe Leu Glu Gln Gln Asn Lys
1 5
<210> 49
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 49
Ala Thr Asp Leu Leu Lys Arg Lys
1 5
<210> 50
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 50
Ala Thr Asp Leu Leu Lys Arg
1 5
<210> 51
<211> 24
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 51
Tyr Ile Glu Leu Val Val Val Ala Asp His Gly Met Phe Thr Lys Tyr
1 5 10 15
Asp Ser Asn Leu Asp Thr Ile Arg
20
<210> 52
<211> 15
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 52
Thr Trp Val His Glu Leu Val Asn Ser Ile Asn Glu Phe Tyr Arg
1 5 10 15
<210> 53
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 53
Asp Ser Arg Val Ile Glu Gly Ile Lys
1 5
<210> 54
<211> 7
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 54
Asn Leu Leu Gln Phe Asn Lys
1 5
<210> 55
<211> 8
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 55
Met Ile Lys Glu Glu Thr Gly Lys
1 5
<210> 56
<211> 9
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 56
Ser Asp Ile Tyr Ser Tyr Ser Leu Lys
1 5
<210> 57
<211> 14
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 57
Arg Asn Leu Asp Thr Tyr Asn Asn Gly Tyr Met Phe Tyr Arg
1 5 10
<210> 58
<211> 10
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 58
Asn Leu Leu Gln Phe Asn Lys Met Ile Lys
1 5 10
<210> 59
<211> 17
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 59
Arg Asn Leu Asp Thr Tyr Asn Asn Gly Tyr Met Phe Tyr Arg Asp Ser
1 5 10 15
Lys
<210> 60
<211> 506
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 60
Met Ser Ala Asn Val Gln Val Met Phe Ser Leu Leu Phe Leu Ala Ala
1 5 10 15
Leu Gly Ser Cys Ala Asn Asp Arg Asn Pro Leu Glu Glu Cys Phe Arg
20 25 30
Glu Thr Asp Tyr Glu Glu Phe Leu Glu Ile Ala Arg Asn Gly Leu Lys
35 40 45
Ala Thr Ser Asn Pro Lys His Val Val Val Val Gly Ala Gly Met Ser
50 55 60
Gly Leu Ser Ala Ala Tyr Val Leu Ser Gly Ala Gly His Gln Val Thr
65 70 75 80
Val Leu Glu Ala Ser Glu Arg Ala Gly Gly Arg Val Arg Thr Tyr Arg
85 90 95
Asn Asp Lys Glu Asp Trp Tyr Ala Asn Leu Gly Pro Met Arg Leu Pro
100 105 110
Glu Lys His Arg Ile Val Arg Glu Tyr Ile Arg Lys Phe Gly Leu Gln
115 120 125
Leu Asn Glu Phe Ser Gln Glu Asn Asp Asn Ala Trp Tyr Phe Ile Lys
130 135 140
Asn Ile Arg Lys Arg Val Gly Glu Val Lys Lys Asp Pro Gly Val Leu
145 150 155 160
Lys Tyr Pro Val Lys Pro Ser Glu Glu Gly Lys Ser Ala Gly Gln Leu
165 170 175
Tyr Glu Glu Ser Leu Gly Lys Val Val Glu Glu Leu Lys Arg Thr Asn
180 185 190
Cys Ser Tyr Ile Leu Asn Lys Tyr Asp Thr Tyr Ser Thr Lys Glu Tyr
195 200 205
Leu Leu Lys Glu Gly Asn Leu Ser Pro Gly Ala Val Asp Met Ile Gly
210 215 220
Asp Leu Met Asn Glu Asp Ser Gly Tyr Tyr Val Ser Phe Pro Glu Ser
225 230 235 240
Leu Arg His Asp Asp Ile Phe Ala Tyr Glu Lys Arg Phe Asp Glu Ile
245 250 255
Val Gly Gly Met Asp Lys Leu Pro Thr Ser Met Tyr Arg Ala Ile Glu
260 265 270
Glu Lys Val His Leu Asn Ala Gln Val Ile Lys Ile Gln Lys Asn Ala
275 280 285
Glu Lys Val Thr Val Val Tyr Gln Thr Pro Ala Lys Glu Met Ala Ser
290 295 300
Val Thr Ala Asp Tyr Val Ile Val Cys Thr Thr Ser Arg Ala Thr Arg
305 310 315 320
Arg Ile Lys Phe Glu Pro Pro Leu Pro Pro Lys Lys Ala His Ala Leu
325 330 335
Arg Ser Val His Tyr Arg Ser Gly Thr Lys Ile Phe Leu Thr Cys Thr
340 345 350
Lys Lys Phe Trp Glu Asp Glu Gly Ile His Gly Gly Lys Ser Thr Thr
355 360 365
Asp Leu Pro Ser Arg Phe Ile Tyr Tyr Pro Asn His Asn Phe Thr Ser
370 375 380
Gly Val Gly Val Ile Ile Ala Tyr Gly Ile Gly Asp Asp Ala Asn Phe
385 390 395 400
Phe Gln Ala Leu Asp Phe Lys Asp Cys Ala Asp Ile Val Ile Asn Asp
405 410 415
Leu Ser Leu Ile His Gln Leu Pro Arg Glu Glu Ile Gln Thr Phe Cys
420 425 430
Tyr Pro Ser Met Ile Gln Lys Trp Ser Leu Asp Lys Tyr Ala Met Gly
435 440 445
Gly Ile Thr Thr Phe Thr Pro Tyr Gln Phe Gln His Phe Ser Glu Ser
450 455 460
Leu Thr Ala Ser Val Asp Arg Ile Tyr Phe Ala Gly Glu His Thr Ala
465 470 475 480
Glu Ala His Gly Trp Ile Asp Ser Thr Ile Lys Ser Gly Leu Arg Ala
485 490 495
Ala Arg Asp Val Asn Arg Ala Ser Glu Gln
500 505
<210> 61
<211> 1521
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 61
atgtcagcaa atgttcaggt tatgttctca ctgctgttct tggctgcctt gggaagctgt 60
gcaaatgaca gaaaccccct agaggaatgc ttccgagaaa ctgactatga agaatttcta 120
gagatcgcca gaaatggtct gaaagcgaca tcaaacccaa aacatgttgt ggttgtaggt 180
gcaggaatgt ctgggcttag tgcagcctat gttctttcag gggctggaca tcaggtgaca 240
gttcttgaag ccagtgaacg tgcgggagga cgagtgagga cttatcgaaa tgacaaagaa 300
gactggtatg ccaatctcgg gcccatgcgt ttacctgaga aacacaggat tgtccgggaa 360
tatatcagaa agtttggtct gcagttgaat gaattttctc aggaaaatga caatgcctgg 420
tattttatca aaaacatcag gaagagagta ggggaagtca agaaagaccc tggcgtcttg 480
aaatatcccg tgaagccttc agaagaaggc aaaagtgctg gacagctata tgaagagtcc 540
ctcggaaagg ttgtagaaga attaaaaagg actaactgca gctacatact aaataaatat 600
gacacctact caacgaagga gtatctactt aaagaaggaa atctgagtcc tggagctgta 660
gatatgattg gagacttaat gaatgaagat tctggctatt atgtgtcttt tcctgaaagc 720
ctgagacatg atgatatctt tgcttatgaa aaaagatttg atgaaattgt tggtggaatg 780
gataagttgc ctacatccat gtatcgagcc attgaggaaa aggtgcattt gaatgcccaa 840
gtaatcaaga tacagaagaa tgccgagaaa gtcacagtgg tatatcaaac cccagcaaag 900
gagatggcat ctgtgacagc tgattatgtc attgtgtgca ctacatcaag ggccacccgt 960
cgcatcaagt ttgaaccacc ccttccgcca aagaaagcgc atgctttgcg gtctgtccac 1020
tacagaagtg gcaccaagat cttcctcact tgcactaaga aattttggga ggatgaaggc 1080
attcatggtg ggaagtccac aactgatctt ccatcccgat tcatctacta ccctaaccat 1140
aactttacta gtggagttgg ggttattata gcctatggca ttggtgatga tgccaatttc 1200
tttcaagctc ttgatttcaa ggactgtgct gatattgtca ttaatgacct ttcattgatc 1260
catcagctgc ctagggaaga gatccagacc ttctgttatc cctcaatgat tcaaaaatgg 1320
agcctggata agtatgctat gggtggtata accaccttca ctccctacca gtttcaacat 1380
tttagtgaat cgctcactgc atctgtagac agaatctatt ttgcagggga gcatacggcc 1440
gaagctcatg gttggattga cagcacaatt aagtcagggc tgagagcagc aagagatgtg 1500
aatcgtgctt ctgagcaatg a 1521
<210> 62
<211> 240
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 62
Met Ile Val Phe Ile Val Leu Pro Ile Leu Ala Ala Val Leu Gln Gln
1 5 10 15
Ser Ser Gly Asn Val Asp Phe Asp Ser Glu Ser Pro Arg Lys Pro Glu
20 25 30
Ile Gln Asn Glu Ile Val Asp Leu His Asn Ser Leu Arg Arg Ser Val
35 40 45
Asn Pro Thr Ala Ser Asn Met Leu Lys Met Glu Trp Tyr Pro Glu Ala
50 55 60
Ala Ala Asn Ala Glu His Trp Ala Tyr Arg Cys Ile Glu Asp His Ser
65 70 75 80
Ser Arg Asp Ser Arg Val Leu Glu Gly Ile Lys Cys Gly Glu Asn Ile
85 90 95
Tyr Met Ser Ser Ile Pro Met Lys Trp Thr Asp Ile Ile His Ile Trp
100 105 110
His Asp Glu Tyr Lys Asn Phe Lys Tyr Gly Ile Gly Ala Asp Pro Pro
115 120 125
Asn Ala Val Ile Gly His Phe Thr Gln Ile Val Trp Tyr Lys Ser Tyr
130 135 140
Arg Ala Gly Cys Ala Ala Ala Tyr Cys Pro Ser Ser Glu Tyr Ser Tyr
145 150 155 160
Phe Tyr Val Cys Gln Tyr Cys Pro Ala Gly Asn Met Arg Gly Lys Thr
165 170 175
Ala Thr Pro Tyr Thr Ser Gly Pro Pro Cys Gly Asp Cys Pro Ser Ala
180 185 190
Cys Asp Asn Gly Leu Cys Thr Asn Pro Cys Thr Gln Glu Asp Leu Phe
195 200 205
Thr Asn Cys Asn Ser Leu Val Gln Gln Ser Ser Cys Gln Asp Asn Tyr
210 215 220
Ile Lys Thr Asn Cys Pro Ala Ser Cys Phe Cys His Asn Glu Ile Lys
225 230 235 240
<210> 63
<211> 723
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 63
atgattgtct tcattgtctt gccaattctt gctgcagtgc tgcaacagtc ttctggaaat 60
gttgattttg attctgagtc acccaggaaa ccagaaatac aaaacgagat tgttgacttg 120
cacaattctt taaggagatc tgtgaatcca actgctagca acatgctaaa aatggaatgg 180
tatcctgaag ctgctgctaa tgcagaacat tgggcgtaca gatgtattga ggatcacagt 240
tcacgcgatt caagagttct tgaaggaata aaatgtggtg aaaatatata tatgtcatct 300
attcctatga aatggactga cattattcac atttggcatg atgaatacaa aaatttcaag 360
tatggcattg gagcagaccc accaaatgct gttattggcc atttcactca gatagtttgg 420
tacaaaagtt accgtgctgg ttgtgctgct gcctattgtc cttcatcgga atacagctac 480
ttctatgttt gtcagtactg cccagcagga aacatgagag gtaaaactgc tactccatat 540
acatcagggc caccttgtgg ggattgtcct tcggcttgtg acaatggact atgcacaaat 600
ccttgcacac aagaagatct gttcacgaac tgcaatagct tggtccaaca aagtagctgc 660
caggataatt atataaagac aaattgccct gcttcttgct tctgccacaa tgaaataaaa 720
tag 723
<210> 64
<211> 138
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 64
Met Arg Thr Leu Trp Ile Met Ala Val Leu Leu Leu Gly Val Glu Gly
1 5 10 15
Ser Leu Val Gln Phe Glu Thr Leu Ile Met Lys Ile Ala Gly Arg Ser
20 25 30
Gly Ile Trp Tyr Tyr Gly Ser Tyr Gly Cys Tyr Cys Gly Ala Gly Gly
35 40 45
Gln Gly Arg Pro Gln Asp Ala Ser Asp Arg Cys Cys Phe Val His Asp
50 55 60
Cys Cys Tyr Gly Lys Val Thr Gly Cys Asn Pro Lys Met Asp Val Tyr
65 70 75 80
Thr Tyr Thr Glu Glu Asn Gly Ala Ile Val Cys Gly Gly Asp Asp Pro
85 90 95
Cys Lys Lys Glu Val Cys Glu Cys Asp Arg Ala Ala Ala Ile Cys Phe
100 105 110
Arg Asp Asn Ile Asp Thr Tyr Asp Asn Lys Tyr Trp Phe Phe Pro Ala
115 120 125
Lys Asn Cys Gln Glu Glu Ser Glu Pro Cys
130 135
<210> 65
<211> 417
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 65
atgaggactc tctggataat ggccgtgttg ctgctgggcg tcgaggggag cctggtgcaa 60
tttgagacgc tgatcatgaa aattgcgggg agaagcggta tttggtacta cggctcttac 120
ggatgctact gcggcgcggg gggccaaggc cggccacagg acgccagcga ccgctgctgc 180
tttgtgcacg actgctgtta tggaaaagtg actggctgca acccaaaaat ggacgtctac 240
acctacaccg aggagaacgg ggctatcgtc tgcggagggg acgacccgtg caagaaggag 300
gtttgtgagt gcgatagggc tgcggcaatc tgcttccgag acaatattga cacatacgac 360
aacaaatatt ggtttttccc ggccaaaaat tgccaggagg agtcagagcc atgctaa 417
<210> 66
<211> 240
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 66
Met Ile Val Phe Ile Val Leu Pro Ile Leu Ala Ala Val Leu Gln Gln
1 5 10 15
Ser Ser Gly Ser Val Asp Phe Asp Ser Glu Ser Pro Arg Lys Pro Glu
20 25 30
Ile Gln Asn Glu Ile Val Asp Leu His Asn Ser Leu Arg Arg Ser Val
35 40 45
Asn Pro Thr Ala Ser Asn Met Leu Lys Met Glu Trp Tyr Pro Glu Ala
50 55 60
Ala Ala Asn Ala Glu Arg Trp Ala Tyr Arg Cys Ile Glu Asp His Ser
65 70 75 80
Ser Arg Asp Ser Arg Val Leu Glu Gly Ile Lys Cys Gly Glu Asn Ile
85 90 95
Tyr Met Ser Thr Ile Pro Met Lys Trp Thr Asp Ile Ile His Ala Trp
100 105 110
His Asp Glu Tyr Lys Asn Phe Lys Tyr Gly Ile Gly Ala Asp Pro Pro
115 120 125
Asn Ala Val Ile Gly His Tyr Thr Gln Ile Val Trp Tyr Lys Ser Tyr
130 135 140
Arg Ala Gly Cys Ala Ala Ala Tyr Cys Pro Ser Ser Glu Tyr Ser Tyr
145 150 155 160
Phe Tyr Val Cys Gln Tyr Cys Pro Ala Gly Asn Ile Arg Gly Lys Thr
165 170 175
Ala Thr Pro Tyr Thr Ser Gly Pro Pro Cys Gly Asp Cys Pro Ser Ala
180 185 190
Cys Asp Asn Gly Leu Cys Thr Asn Pro Cys Thr Gln Glu Asp Val Tyr
195 200 205
Thr Asn Cys Asn Ser Met Val Gln Gln Ser Ser Cys Gln Asp Asn Tyr
210 215 220
Ile Lys Thr Asn Cys Pro Ala Ser Cys Phe Cys His Asn Glu Ile Lys
225 230 235 240
<210> 67
<211> 723
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 67
atgattgtct tcattgtctt gccaattctt gctgcagtgc tgcaacagtc ttctggaagt 60
gttgattttg attctgagtc acccaggaaa ccagaaatac aaaacgagat tgttgacttg 120
cacaattctt taaggagatc tgtgaatcca actgctagca acatgctaaa aatggaatgg 180
tatcctgaag ctgctgctaa tgcagaacgt tgggcgtaca gatgtattga ggatcacagt 240
tcacgcgatt caagagttct tgaaggaata aaatgtggtg aaaatatata tatgtcaact 300
attcctatga aatggactga cattattcac gcttggcatg atgaatacaa aaatttcaag 360
tatggcattg gagcagaccc accaaatgct gttattggcc attacactca gatagtttgg 420
tacaaaagtt accgtgctgg ttgtgctgct gcctattgtc cttcatcgga atacagctac 480
ttctatgttt gtcagtactg cccagcagga aacatcagag gtaaaactgc tactccatat 540
acatcagggc caccttgtgg ggattgtcct tcggcttgtg acaatggact atgcacaaat 600
ccttgcacac aagaagatgt gtacacgaac tgcaatagca tggtccaaca aagtagctgc 660
caggataatt atataaagac aaattgccct gcttcttgct tctgccacaa tgaaataaaa 720
tag 723
<210> 68
<211> 139
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 68
Met Arg Thr Leu Trp Ile Met Ala Val Leu Leu Leu Gly Val Glu Gly
1 5 10 15
Ser Leu Val Gln Phe Glu Thr Leu Ile Met Lys Ile Ala Gly Arg Ser
20 25 30
Gly Ile Trp Tyr Tyr Gly Ser Tyr Gly Cys Tyr Cys Gly Ala Gly Gly
35 40 45
Gln Gly Arg Pro Gln Asp Ala Ser Asp Arg Cys Cys Phe Val His Asp
50 55 60
Cys Cys Tyr Gly Lys Val Thr Gly Cys Asp Pro Lys Met Asp Val Tyr
65 70 75 80
Thr Tyr Thr Glu Glu Asn Gly Ala Ile Val Cys Gly Gly Asp Asp Pro
85 90 95
Cys Lys Lys Gln Ile Cys Glu Cys Asp Lys Asp Ala Ala Ile Cys Phe
100 105 110
Arg Asp Asn Ile Asp Thr Tyr Asp Asn Lys Tyr Trp Phe Phe Pro Ala
115 120 125
Lys Asn Cys Pro Ala Glu Glu Ser Glu Pro Cys
130 135
<210> 69
<211> 420
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 69
atgaggactc tctggataat ggccgtgttg ctgctgggcg tcgaggggag cctggtgcaa 60
tttgagacgc tgatcatgaa aattgcgggg agaagcggta tttggtacta cggctcttac 120
ggatgctact gcggcgcggg gggccaaggc cggccacagg acgccagcga ccgctgctgc 180
ttcgtgcacg actgctgtta tggaaaagtg actggctgcg acccaaaaat ggacgtctac 240
acctacaccg aggagaacgg ggctatcgtc tgcggagggg acgacccgtg caagaagcag 300
atttgtgagt gcgacaagga tgcggcaatc tgcttccgag acaatattga cacatacgac 360
aacaaatatt ggtttttccc ggccaaaaat tgcccggcgg aggagtcaga gccatgctaa 420
420
<210> 70
<211> 489
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 70
Met Ser Gln Leu Thr Ser Phe Ser Ser Arg Ser Ala Thr Ala Pro Ser
1 5 10 15
Asn Phe Ser Gln Val Arg Ile Ser Ser Val Ser Ser Ser Arg Gly Ile
20 25 30
Arg Gly Ser Gly Ser Phe Arg Lys Pro Gly Ala Phe Ala Ser Thr Ser
35 40 45
Leu Tyr Asn Leu Gly Ser Ser Ser Arg Arg Ile Ala Ser Ser Phe Pro
50 55 60
Val Ser Pro Ser Leu Gly Tyr Gly Gly Gly Ile Gln Glu Val Thr Ile
65 70 75 80
Asn Gln Asn Leu Leu Ser Pro Leu Asn Leu Glu Ile Asp Pro Thr Ile
85 90 95
Gln Lys Val Arg Lys Glu Glu Lys Glu Gln Ile Lys Val Leu Asn Asn
100 105 110
Lys Phe Ala Ser Phe Ile Asp Lys Val Arg Phe Leu Glu Gln Gln Asn
115 120 125
Lys Met Leu Glu Thr Lys Trp Asn Ile Leu Gln Gln Gln Lys Thr Ser
130 135 140
Thr Arg Asn Asn Thr Ala Pro Val Phe Asp Ala Tyr Ile Asn Asn Leu
145 150 155 160
Arg Arg Gln Leu Asp Ser Leu Gln Asn Asp Lys Gly Arg Leu Glu Gly
165 170 175
Glu Leu Lys Asn Met Gln Asp Leu Val Glu Asp Phe Lys Asn Lys Tyr
180 185 190
Glu Asp Glu Ile Asn Lys Arg Thr Thr Ala Glu Asn Asp Phe Val Val
195 200 205
Leu Lys Lys Asp Val Asp Ala Ser Tyr Met Asn Lys Val Glu Leu Glu
210 215 220
Ala Arg Val Asp Gly Leu Thr Asp Glu Ile Asn Phe Leu Arg Ala Leu
225 230 235 240
Tyr Glu Ala Glu Leu Ala Glu Leu Gln Asn Gln Val Ser Asp Thr Ser
245 250 255
Val Ile Leu Gln Met Asp Asn Asn Arg Asn Leu Asp Leu Asp Ser Ile
260 265 270
Ile Ala Glu Val Lys Ala Gln Tyr Glu Glu Ile Ala Asn Lys Ser Arg
275 280 285
Lys Glu Ala Glu Ser Trp Tyr Gln Ser Lys Phe Glu Ala Leu Gln Ala
290 295 300
Thr Ala Gly Lys His Gly Asp Asp Leu Arg Ser Thr Arg Asn Glu Ile
305 310 315 320
Ala Glu Ile Asn Arg Leu Ile Leu Arg Leu Gln Ala Glu Ile Asp His
325 330 335
Val Lys Asn Gln Arg Val Lys Leu Glu Asp Ala Ile Ala Glu Ala Glu
340 345 350
Glu Arg Gly Thr Leu Ala Val Lys Asp Ala Lys Ala Lys Leu Glu Glu
355 360 365
Leu Glu Val Ala Met Asn Lys Ala Lys Gln Glu Met Ala Leu Gln Leu
370 375 380
Arg Glu Tyr His Glu Leu Met Asn Val Lys Leu Ala Leu Asp Ile Glu
385 390 395 400
Ile Ala Thr Tyr Arg Lys Leu Leu Glu Gly Glu Glu Ser Arg Leu Ser
405 410 415
Gly Asp Gly Ala Gly Ser Val Ser Met Thr Leu Val Ser Ser Gly Gly
420 425 430
Gly Ser Gly Gly Gly Ala Tyr Ser Ser Gly Ser Gly Leu Gly Tyr Gly
435 440 445
Gly Gly Phe Thr Leu Gly Ser Gly Met Gly Ser Gly Ala Leu Gly Phe
450 455 460
Thr Ser Gly Val Gly Ser Gly Ser Leu Lys Ser Thr Tyr Ser Val Thr
465 470 475 480
Ser Thr Ser Arg Arg Ser Met Arg Asn
485
<210> 71
<211> 1471
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 71
atgtcgcagc tgacttcatt cagttctcgt tcagcaactg ccccttctaa cttttcccaa 60
gtccggatca gctctgtttc ttcatcgcgt ggaatcagag ggagtggaag ttttaggaag 120
ccaggtgcct ttgctagcac cagtttgtat aacttgggct ccagcagcag gaggattgcc 180
tcgtctttcc ctgtctcacc ttcgcttgga tatggcggtg gtattcaaga agtcactatt 240
aatcagaatc tcttgtcccc actcaacctg gaaattgacc caaccatcca gaaggtgcgc 300
aaggaggaga aggagcagat taaggtcctc aacaacaaat ttgcatcctt cattgacaag 360
gtccgattcc ttgagcagca aaataaaatg ctggagacca aatggaacat cttacagcag 420
caaaagacca gcactcggaa caacactgca cccgtctttg acgcgtacat taacaacctg 480
cggagacagc tagacagctt gcagaatgac aagggacggc tggaaggaga actgaagaac 540
atgcaggatc ttgttgagga ttttaagaac aagtatgaag atgaaatcaa caagcgcacc 600
actgcagaga atgattttgt tgtgctcaaa aaagatgttg atgcttccta catgaataag 660
gtggagctgg aagccagagt ggatgggctg acagatgaaa taaatttcct gagagcgctt 720
tatgaagcag aactggctga attgcagaac caggtctctg atacatctgt tatcctccaa 780
atggacaaca atcggaatct ggacttggac agtatcattg ctgaggtcaa agctcagtat 840
gaggagattg ctaataagag caggaaggag gcagaaagct ggtaccaaag caagtttgag 900
gccttgcaag ccactgctgg aaagcatgga gatgacctgc ggagcacaag gaatgagatt 960
gcagagatta atcgcctaat attgaggctg caagctgaga ttgaccatgt gaaaaaccag 1020
cgtgtcaagc ttgaagatgc cattgctgaa gcagaagaac gcggtacgtt ggctgtcaaa 1080
gatgccaagg cgaaactaga ggagctggag gtggccatga acaaagctaa gcaagagatg 1140
gccctccagc tgcgtgaata tcacgagctg atgaatgtca agctggctct ggatattgag 1200
attgctactt acagaaagct gctggaagga gaagagagca gattgtctgg agacggagct 1260
ggttctgtaa gcatgaccct ggtcagctcc ggtggtggta gtggtggtgg tgcatacagc 1320
agcggaagtg gtcttggcta tggtggagga tttactctgg gaagtggaat gggcagcgga 1380
gccctcggtt tcacctctgg agttggctca ggcagcctga aatcgacata cagtgtgaca 1440
agcacatcca ggagaagcat gagaaattga g 1471
<210> 72
<211> 140
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 72
Met Arg Thr Leu Trp Ile Met Ala Val Leu Leu Leu Gly Val Glu Gly
1 5 10 15
Ser Leu Ile Gln Phe Glu Thr Leu Ile Met Lys Val Ala Lys Lys Ser
20 25 30
Gly Met Phe Trp Tyr Asn Asn Tyr Gly Cys Tyr Cys Gly Trp Gly Gly
35 40 45
Gln Gly Arg Pro Gln Asp Ala Thr Asp Arg Cys Cys Phe Val His Asp
50 55 60
Cys Cys Tyr Gly Lys Val Thr Gly Cys Asp Pro Lys Met Asp Val Tyr
65 70 75 80
Ser Phe Ser Glu Glu Asn Gly Asp Ile Val Cys Gly Gly Asp Asp Pro
85 90 95
Cys Lys Lys Glu Ile Cys Glu Cys Asp Arg Ala Ala Ala Ile Cys Phe
100 105 110
Arg Asp Asn Leu Asn Thr Tyr Asn Asp Lys Lys Tyr Trp Ala Phe Gly
115 120 125
Ala Lys Asn Cys Pro Gln Glu Glu Ser Glu Pro Cys
130 135 140
<210> 73
<211> 423
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 73
atgaggactc tctggataat ggccgtgttg ctgctgggcg tcgaggggag cctgattcaa 60
tttgagaccc tgatcatgaa agtggcgaag aaaagtggta tgttttggta caacaattat 120
ggatgctact gcggctgggg gggccaaggc cggccacagg acgccactga ccgctgctgc 180
tttgtgcatg actgctgtta cggaaaagtg accggctgtg accccaaaat ggacgtctat 240
tccttcagcg aggagaacgg ggatattgtc tgcggagggg acgacccgtg caagaaggag 300
atttgtgagt gcgatagggc cgcggcaatc tgcttccgag acaatctgaa cacatacaat 360
gacaaaaaat attgggcgtt cggggccaaa aattgcccgc aggaggagtc agagccatgt 420
taa 423
<210> 74
<211> 138
<212> PRT
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 74
Met Arg Thr Leu Trp Ile Met Ala Val Leu Leu Leu Gly Val Glu Gly
1 5 10 15
Asn Leu Leu Gln Phe Asn Lys Met Ile Lys Glu Glu Thr Gly Lys Asn
20 25 30
Ala Ile Pro Phe Tyr Ala Phe Tyr Gly Cys Tyr Cys Gly Trp Gly Gly
35 40 45
Gln Gly Lys Pro Lys Asp Gly Thr Asp Arg Cys Cys Phe Val His Asp
50 55 60
Cys Cys Tyr Gly Arg Leu Pro Asn Cys Asn Thr Lys Trp Asp Ile Tyr
65 70 75 80
Ser Tyr Ser Leu Lys Asp Gly Tyr Ile Thr Cys Gly Lys Gly Thr Trp
85 90 95
Cys Glu Glu Gln Ile Cys Glu Cys Asp Arg Val Ala Ala Glu Cys Phe
100 105 110
Arg Arg Asn Leu Asn Thr Tyr Asn Asn Gly Tyr Met Phe Tyr Arg Asp
115 120 125
Ser Lys Cys Thr Glu Thr Ser Glu Glu Cys
130 135
<210> 75
<211> 417
<212> DNA
<213> Artificial Sequence
<220>
<223> Artificail sequence
<400> 75
atgaggactc tctggataat ggccgtgttg ctgctgggcg tcgaggggaa cctgctgcaa 60
ttcaacaaga tgatcaagga agagacgggg aaaaacgcta ttcccttcta tgccttttac 120
ggctgctact gtggctgggg gggccaaggc aagccaaagg acggcacaga ccgctgctgc 180
tttgtgcacg actgctgtta cggaagactg cccaactgca acaccaaatg ggacatctat 240
tcctacagct tgaaggatgg gtatatcacc tgcggaaagg gcacctggtg cgaggaacag 300
atttgtgagt gcgacagggt cgcggcagaa tgcttcagaa ggaatctgaa cacgtacaat 360
aatggatata tgttttaccg ggactcaaaa tgcacggaga cttcagagga atgctaa 417
Claims (8)
- 살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 1 내지 21 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
- 청구항 1에 있어서, 상기 조성물에 포함되는 혈청은 불활성화한 살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
- 청구항 1에 있어서, 메탈로프로테아제 억제제를 더 포함하는. 한국형 살무사과 사독의 항사독 조성물.
- 까치살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 22 내지 39 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
- 청구항 4에 있어서, 상기 조성물에 포함되는 혈청은 불활성화한 까치살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
- 쇠살무사 독을 주입한 동물로부터 얻어진 혈청을 포함하고,
혈청에 서열번호 40 내지 57 중 적어도 하나의 펩타이드가 존재하는 교상 환자의 항사독용인, 한국형 살무사과 사독의 항사독 조성물.
- 청구항 6에 있어서, 상기 조성물에 포함되는 혈청은 불활성화한 쇠살무사 독을 면역항원보강제와 함께 주입한 동물로부터 얻어진 것인, 한국형 살무사과 사독의 항사독 조성물.
- 청구항 6에 있어서, 메탈로프로테아제 억제제를 더 포함하는. 한국형 살무사과 사독의 항사독 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210081139A KR20220170290A (ko) | 2021-06-22 | 2021-06-22 | 한국형 살무사과 사독의 항사독 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210081139A KR20220170290A (ko) | 2021-06-22 | 2021-06-22 | 한국형 살무사과 사독의 항사독 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220170290A true KR20220170290A (ko) | 2022-12-29 |
Family
ID=84539658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210081139A KR20220170290A (ko) | 2021-06-22 | 2021-06-22 | 한국형 살무사과 사독의 항사독 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220170290A (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100350906B1 (ko) | 2000-06-14 | 2002-09-05 | (주)바이오버드 | 뱀의 독소로부터 분리된 신규한 트롬빈 유사효소 및 그의제조방법 |
-
2021
- 2021-06-22 KR KR1020210081139A patent/KR20220170290A/ko not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100350906B1 (ko) | 2000-06-14 | 2002-09-05 | (주)바이오버드 | 뱀의 독소로부터 분리된 신규한 트롬빈 유사효소 및 그의제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Monteiro et al. | Bothrops atrox, the most important snake involved in human envenomings in the amazon: How venomics contributes to the knowledge of snake biology and clinical toxinology | |
US20190300583A1 (en) | Neurotoxins for use in inhibiting cgrp | |
CN1328285C (zh) | 干细胞增殖抑制因子及其应用 | |
JP2011503012A (ja) | 予後に関するバイオマーカーおよび治療の分子標的としての細胞外ヒストン | |
KR20190135519A (ko) | 섬유성 질환의 치료약 | |
CN108840923A (zh) | 一种靶向pd-l1的多肽及其应用 | |
CN102724994A (zh) | 用于治疗炎性疾病和病症的方法 | |
Tan et al. | Snakebite in Southeast Asia: envenomation and clinical management | |
Tan et al. | King Cobra and snakebite envenomation: On the natural history, human-snake relationship and medical importance of Ophiophagus hannah | |
KR20220170290A (ko) | 한국형 살무사과 사독의 항사독 조성물 | |
Xie et al. | Agkihpin, a novel SVTLE from Gloydius halys Pallas, promotes platelet aggregation in vitro and inhibits thrombus formation in vivo in murine models of thrombosis | |
Cherkasova | Experimental Modeling of Sepsis | |
Walker et al. | Pathogenesis, immunity, pathology, and pathophysiology in rickettsial diseases | |
Montealegre-Sánchez et al. | Individual variations in the protein profiles and functional activities of the eyelash palm pit-viper (Bothriechis schlegelii) venom from the Colombian southwest region | |
US8568741B2 (en) | Botulinum toxin for smoking cessation | |
KR102505221B1 (ko) | 한국형 살무사과 사독 감별용 조성물 | |
JP3823268B2 (ja) | ヘリコバクター・ピロリの細胞死誘導剤 | |
JPH07196689A (ja) | 寄生虫に対する感染防御のための抗原及びその用途 | |
KR101744423B1 (ko) | Malassezia restricta로부터 분리한 신규 Lipase 유전자 및 이의 용도 | |
Bolton | Incorporating the 3RS (Refinement, Replacement and Reduction of Animals in Research) into the Preclinical Assessment of Snake Venom Toxicity and Antivenom Efficacy | |
Giri et al. | Combating the Insidious Enemy: Epidemiology, Pathophysiology, and Treatment of Clostridial Gas Gangrene | |
CN112480242B (zh) | Spink7蛋白在制备预防和/或治疗溃疡性结肠炎的药物中的应用 | |
CN101602793B (zh) | 用于预防和/或治疗类风湿性关节炎的免疫调节多肽及其应用 | |
Lyons | VIPER STRIKE OUT: THE HISTORY AND CURRENT RESEARCH OF SNAKE ANITVENOM | |
Azuma et al. | The effects of cure of Helicobacter pylori infection on the signal transduction of gastric epithelial cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |